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21 GENERAL INTRODUCTION
This dissertation describes work towards the goal of characterizing an important superfamily
of cell receptor proteins in two prominent organisms. This is of interest from an infectious
disease and human health standpoint, as well as a purely biological standpoint. The protein
superfamily investigated is the G protein-coupled receptor (GPCR) family. Extensive efforts
were made to delineate the receptor complements of the human parasite Schistosoma mansoni
and the model organism Schmidtea mediterranea. Further work primarily focuses on validation
of a novel method for elucidating receptor function in the native cell membrane environment.
The first chapter of this dissertation describes these biomolecules and organisms in appropriate
depth, justifies the significance of the research topic, and outlines a hypothesis-driven research
plan, and serve as a general foundation for the research manucripts that follow. These works are
tied together and discussed in the final chapter, where future avenues of research are suggested.
The appendices include various supplementary documents and my summarized contributions
to related published work that are referenced within manuscripts.
1.1 Schistosomes: Significant Human Parasites
Schistosomes are trematodes of the phylum Platyhelminths, and etiological agents of schisto-
somiasis. In their parasitic capacity, schistosomes continue to pose a significant challenge to
human health. Recent estimates place the number of infected humans at a staggering 207
million across 74 countries, with 280,000 deaths per annum attributed to schistosomiasis in
sub-Saharan Africa alone [1]. In endemic areas, another 779 million people are thought to be
at risk of infection [2]. It is calculated that 70 million disability-adjusted life years (DALYs)
3are lost to schistosomiasis annually [2, 3]. This figure surpasses the global burdens posed by
both malaria and tuberculosis, and is nearly equivalent to that of HIV/AIDS [4]. To further
exacerbate the situation, there exists strong evidence that the prevalence of this disease helps
account for the disproportionately high HIV-1 infection rates observed in aﬄicted areas [5].
The genus Schistosoma contains a number of species that infect humans, with varying geo-
graphic distributions. Among these, Schistosoma mansoni, Schistosoma japonicum, and Schis-
tosoma haematobium account for a prevalence of infections. S. mansoni and S. japonicum
cause intestinal schisotomiasis, while S. haematobium leads to urogenital schistosomiasis. The
wide range of species-specific clinical manifestations associated with chronic schistosomiasis
have been well described. These include persistent inflammation, and morbidity brought on by
anemia, diarrhea, chronic abdominal pain, fatigue, malnutrition, and childhood stunting [6].
While there is great variance in the severity of pathologies, the overall health and economic
impact of this disease is a crippling factor in many developing countries. The relative lack
of attention schistosomiasis receives with respect to its human health burden has led to its
classification as a neglected tropical disease (NTD).
At present, this overwhelming disease burden is met with a near exclusive reliance on treat-
ment with the drug praziquantel. Significant advances in schistosomiasis control have been
achieved in the past few years, due primarily to well-organized control programs that include
aggressive chemotherapy [7, 8]. While these programs produce unquestionable public health
benefit, their assertive use of praziquantel raises well-founded concerns regarding the long-term
efficacy of this approach. Alarming reports of emerging drug resistance and the potential for re-
sistance [9,10] have spurred recognition of the pressing need for new antischistosomals [1,11–15].
The schistosome life cycle is complex, requiring an intermediate fresh water host. We can begin
description of this life cycle with the deposition of schistosome eggs into water. The eggs hatch
and release motile miracidia, which parasitize snails as an intermediate host. These miracadia
4then develop into sporocysts within the intermediate snail host. After successive generations,
free-living cercariae emerge and are released into water. Cercareae penetrate human skin and
transition into schistosomulae. Schistosomules enter the venous circulatory system and travel
to the lungs. From there, they migrate to the hepatic portal system where they undero sexual
maturation and develop into male and female adults. Adult mate pairs migrate to a final in-
fection site in a species-dependent manner: either the mesenteric venules of the small intestine
(intestinal schistosomiasis), or the venous plexus of the bladder (urinary schistosomiasis). The
female parasites produce hundreds to thousands of eggs daily. These eggs pass through the
lumen wall and are then expelled in feces or urine, allowing the life cycle to begin anew. The
life cycle is displayed in Figure 1.1.
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Figure 1.1 Schistosome life cycle.
The schistosome life-cycle is depicted in linearized fashion. Life stages: egg (E), miracidium (M),
sporocyst (S), cercaria (C), schistosomule (S), and adult (A). Intermediate host (snail) and host (human)
stages are outlined.
1.2 Planarians: Robust Model Organisms
Planarians are free-living bilateral organisms of the phylum Platyhelminthes. The remarkable
regenerative capabilities of these organisms and their evolutionary position as basal metazoans,
have advanced their use as a model system to study stem cell biology and development [16–18].
The planarian body is seeded with stem cells exhibiting totipotency. These ‘neoblasts’ con-
stitute > 20% of the total organismal cell count and exhibit the capacity to differentiate into
5any of the estimated 40 planarian cell types [19]. Planarians are hermaphroditic and rely on
either or both sexual or asexual modes of reproduction to propagate, in a species-dependent
manner. Asexual reproduction occurs via transverse fission along the anteroposterior axis, and
can be promoted by various environmental cues including population density and light-dark
cycles [20,21]. A large number of planarian species exist with varying reproductive modes com-
plicated by varying ploidy. Among these, Schmidtea mediterranaea is the most widely studied.
S. mediterranaea is a stable diploid (2n = 8) with a relatively small haploid genome. Inter-
estlingly, a Robertsonian chromosomal translocation involving the fusion of the whole arm of
chromosome 1 to chromosome 3 has generated exclusively asexual strains of this species [22].
Both sexual and asexual strains are easily maintained and propagated in the laboratory. Clonal
asexual lines derived by serial amputation severely limit genetic variation and are therefore ideal
for experimental manipulation and examination of genome content. Other planarian species,
such as Dugesia tigrina and Dugesia japonica, are also widely studied with respect to their
strong regenerative abilities. However, their mixoploid genomes (2n = 16 and 3n = 24) cou-
pled with the presence of large numbers of transposable elements [23], complicate genomic
analyses. In the course of this work, we make use of S. mediterranaea and D. tigrina.
1.3 Genomics
The most recent release of the S. mansoni genome is in the form of a 381 Mb assembly dis-
playing approximately 6X coverage, accompanied by a set of 11,812 predicted proteins [24].
Schistosome genomic DNA was isolated and prepared using standard methods from mixed-sex
cercariae of the Puerto Rico isolate. Whole-genome shotgun Sanger sequencing was performed
on insert-containing plasmid, fosmid, and bacterial artificial chromosomes (BAC) libraries. The
final predicted gene set resulted from the application of multiple ab initio gene prediction al-
gorithms that were further refined with transcriptome data and information incorporated from
the S. japonicum genome [25]. A manually curated subset of 402 schistosome gene models
served as a training input for the predition algorithms employed.
6The current S. mediterranea genomic assembly is estimated at ∼ 865 Mb in length at 11X
sequencing depth. A similar WGS (whole-genome shotgun) sequencing approach was used,
whereby plasmid and fosmid libraries were constructed with genomic DNA purified from the
clonally derived S2F2 strain. The predicted S. mediterranea proteome arises from 30,930 gene
models that were produced by MAKER [26,27], an automated genome annotation pipeline that
makes use of a number of gene prediction tools and available EST (expressed sequence tag) col-
lections. However, there is evidence to suggest that this may be a vast overestimate of the true
planarian gene count. In order to refine this figure, 31 S. mediterranea mRNAs were sequenced
and aligned with the assembled genome and compared to corresponding MAKER predictions.
This exercise generated estimates of transcripts represented in the MAKER gene set (90%),
as well as transcripts extending across multiple contigs (30%) and transcripts incorrectly split
into multiple gene models (15%). Extrapolation of these figures to the whole genome indicates
a more reasonable protein-coding gene count of 15,570. Table 1.1 presents the current state of
both nuclear genomic assemblies.
S. mansoni S. mediterranea
Size 363 Mb 865 Mb
Assembly v3.1 v3.1
Coverage 6X 11.6X
Repeats 45% 46%
A/T Richness 65% 69%
Contigs 31,407 94,682
C N50 17,677 19,025
Supercontigs 5,745 43,294
SC N50 879,876 40,862
Gene Prediction ↓ ↓
Genes 11,809 39,930* (15,570)
Table 1.1 Genome assembly statistics.
71.4 Functional Genomics: RNA Interference
The recent arrival of flatworm whole genome sequence data opens avenues for functional ap-
proaches to investigating the molecular physiology of both schistosomes and planarians. Careful
enlistment of these genomic resources alongside improved helminth gene manipulation proto-
cols, will aid in deciphering mechanisms of parasite survival and pathogenesis and may lead
to new strategies for parasite control and elimination. Although significant strides have been
made towards developing flatworm transgenic approaches [28,29], readily-adaptible and robust
protocols are still lacking. In the case of schistosomes, this effort is hampered by the complex
parasite life cycle which only allows for time-restricted maintenance of specific life stages in
vitro [30]. Reports of the successful introduction of transgenes in schistosomes have thus far
been transient and stage-specific, involving electroporation as a means of delivery [31,32]. The
potential for germ line transgenesis [33] could eventually yield parasite strains with heritable
loss-of-function and gain-of-function genotypes. Advances in parasite culture techniques could
conceivably catalyze this recognized and worthwhile goal.
The best-established functional genomics tool available for the study of both pathogenic and
free-living flatworms is RNA interference (RNAi). RNAi was first discovered in the nematode
Caenorhabditis elegans, where introduction of exogenous double-stranded RNA (dsRNA) was
shown to result in sequence-specific gene supression [34,35]. This phenomenon has been shown
to extend to protozoa and nearly all higher-order eukaryotes examined, and has rapidly become
a standard tool for loss-of-function gene analysis. Long dsRNAs can elicit potent gene sup-
pression when introduced into worms, flies, and plants [36]. In mammalian cells, much shorter
silencing triggers are required to avoid a non-specific interferon response (IFN) [37]. What
follows is an outline of the basic components of the canonical RNAi pathway.
1.4.1 Canonical RNAi Pathway
In general, the RNAi pathway involves the association of small non-coding RNAs (ncRNAs)
with a ribonucleoprotein complex dubbed the RNA-induced silencing complex (RISC). RISC
8uses sequence information from a guide strand to downregulate the translation of comple-
mentary mRNAs via transcript cleavage or translational block. The RISC-mediated silencing
pathways triggered by small ncRNAs that originate from exogenously-applied long dsRNAs
and endogenous microRNAs (miRNAs) essentially converge after a series of RNA processing
events. Other pathways involving ncRNAs derived from single stranded RNA (ssRNA) precur-
sors such as piwi-interacting RNAs (piRNAs) are set aside in this overview.
Exogenous dsRNAs are first processed into ∼ 21-25 nt dsRNAs by the RNase III family ribonu-
clease Dicer [38]. Dicer contains a PAZ domain which recognizes dsRNA helical ends, and two
catalytic RNase III domains which cleave individual strands to produce siRNA duplexes with 2
nt 3’ overhangs [39]. The distance beetween the PAZ and RNase III domains corresponds to the
length of the siRNA duplexes produced. The guide strand incorporated into RISC is determined
by the relative thermodynamic stability of the 5’ ends of the two siRNA duplex strands [39–41].
In the microRNA pathway, genomically-encoded miRNAs are first transcribed by RNA poly-
merase II as long pri-miRNAs with a 5’ cap and a poly-A tail [42,43]. Pri-miRNAs are processed
in the nucleus by a complex consisting of the RNase III enzyme Drosha and the dsRNA-binding
protein Pasha, yielding ∼ 65-70 nt pre-miRNAs folded into stem-loop structures. Following ex-
port to the cytoplasm, pre-miRNAs are recognized and cleaved into imperfect miRNA:miRNA*
duplexes by Dicer. As with siRNA duplexes, the mature miRNA guide strand is selected for
incorporation into the RISC complex based on the relative thermodynamic stability of the 5’
ends of the two miRNA duplex strands.
The RISC complex contains members of the Argonaute (Ago) protein family [44]. Argonaute
proteins play a role in guide strand selection and direct endonuclease activity against mRNA
transcripts complementary to their bound siRNA or miRNA guide fragment. The strand that
displays lower stability base pairing in its 5’ end preferentially associates with RISC, and its
complementary passenger strand is degraded as the first RISC substrate. At this juncture in
9the pathway, the origin of the silencing trigger (siRNA or miRNA) does not affect the mechan-
ims of downstream post-transcriptional silencing. This is instead determined by the degree of
complementarity between the guide strand and a target transcript. miRNAs tend to exhibit
partial complementarity to the 3’ UTR of one or more target transcripts, leading to transla-
tional repression [45]. This allows for cell-type and tissue specific gene regulation [46]. Perfect
or near-perfect complementarity between siRNAs or miRNAs and their target transcripts leads
to transcript cleavage.
In plants and nematodes, RNAi can be a systemic phenomenon. Cell-to-cell dispersion of
silencing triggers in C. elegans involves a dsRNA channel (SID-1), which acts as a conduit for
the rapid energy-independent import of dsRNA. There is evidence to suggest that alternative
SID-1-independent pathways are responsible for the export of dsRNA from cells [47]. Most
examined animals, except some insects, house at least a single SID-1 homolog. Less universally
conserved mechanisms that improve RNAi efficiency include distinct pathways for the biogenesis
of secondary siRNAs. In C. elegans, this form of signal amplification occurs via RNA-dependent
RNA polymerase (RdRP) activity [48].
1.4.2 RNAi in Schistosomes
RNAi in schistosomes provides new opportunities for focused exploitation of genomic data. It
is clear that schistosomes possess the cellular machinery that mediates RNAi, with a number
of key molecular actors bioinformatically identified or characterized [49–53]. These include
a single Dicer homolog (smDicer), two Drosha homologs (SmDrosha1 & 2), four Argonaute
homologs (SmAgo1-4), and a SID-1 homolog. The latter suggests that these parasites retain
cell-to-cell dsRNA transport mechanisms similar to C. elegans. miRNAs have also been iden-
tified in silico in both S. mansoni and S. japonicum [54–56], further establishing the presence
of the canonical miRNA-processing and RNAi pathway in schistosomes.
Since the original publications documenting RNAi in S. mansoni [57, 58], there has been an
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accumulation of published accounts of gene silencing in S. mansoni life stages including adults,
schistosomules, sporocysts and eggs [51,59–70]. For the most part, silencing has been reported
for abundantly expressed genes associated with the surface tissues or gut using dsRNA or siRNA
triggers, such that the RNAi-susceptibility of genes associated with other tissue types is unclear.
For example, the silencing of 32 different genes in the developing sporocyst revealed variable
knockdown efficiencies and some off-target silencing, demonstrating the need to optimize and
validate RNAi on a gene-by-gene basis [67].
1.4.3 RNAi in Planaria
Double-stranded RNA has been found to be useful for inducing acute gene silencing in planaria.
The susceptibility of planarians such as S. mediterranea to dsRNA-mediated gene interference
has been well demonstrated. RNAi was first shown to lead to both specific and near complete
gene inhibition with a microinjection protocol [71]. As with schistosomes, miRNAs have been
identified in silico in planaria [72–74]. With the required internal machinery established, other
protocols have since been described to achieve the desired silencing effect in planarians, in-
cluding soaking [75] and bacterial feeding [76, 77] as a means of dsRNA delivery. The latter
involves transforming RNAi vector constructs into RNase III-deficient bacterial cells, induction
of dsRNA synthesis, and ingestion of dsRNA-containing bactera by planarians. This method
has already been utilized in a high-throughput manner to examine the effects genes may have
on regeneration and stem cell function by noting developmental and morphological defects, as
well as other behavioral phenotypes [78].
1.5 G Protein-Coupled Receptors
G protein-coupled receptors (GPCRs) represent the largest known superfamily of proteins in the
metazoa. Relevant to our aims, GPCRs are long-established as lucrative targets for therapeutic
intervention, acting as targets for 50% of all prescription pharmaceuticals [79]. This is undoubt-
edly a function of their extensive role in eukaryotic signal transduction, and more precisely,
their involvement in a myriad of consequential stimulus-response pathways. Sequence diversity
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within the GPCR superfamily is matched appropriately by diversity in the panel of known
exogenous and endogenous ligands [80]. Although GPCRs respond to a range of molecules that
include biogenic amines, peptides, odorants and classical neurotransmitters, they are defined
by a common structural motif: a core domain of well-conserved seven transmembrane-spanning
(7TM) α-helices.
1.5.1 Signal Transduction
GPCRs transduce extracellular signals to intracellular signaling cascades by acting as guanine
nucleotide exchange factors (GEFs). The activation of a GPCR by its cognate ligand promotes
GDP-GTP exchange in associated heterotrimeric G proteins, comprised of an α subunit and
a βγ dimer. The GTP-bound Gα subunit then dissociates from the dimer and activates a
particular biochemical pathway, depending on its subtype. Gαs, Gαi/o, Gαq/11, and Gα12/13
constitute the larger G protein family groupings (Table 1.2) [81]. G proteins exert biochemical
influence on effector molecules, leading to downstream accumulation or reduction of second-
messengers. This can lead to changes in the activity of metabolic enzymes, ion channels,
transporters, and the cellular transcriptional machinery, producing a biological effect. Al-
though GPCR signaling is complex and can include G protein-independent pathways [82], the
primary G protein-dependent pathways that result from receptor activation are the cAMP and
phosphatidylinositol pathways [83].
Family Gα Subtype
Gi/o Gi, Go, Gt, Ggust, Gz
Gs Gs, Golf
Gq/11 Gq, G11, G14, G15, G16
G12/13 G12, G13
Table 1.2 Heterotrimeric G protein classification.
Gαs and Gαi stimulate and inhibit the membrane-associated effector adenylate cyclase, which
catalyzes the conversion of ATP to the second-messenger 3’,5’-cyclic AMP (cAMP), respec-
tively. Gαq/11 acts on the membrane-bound effector phospholipase C beta (PLC-β), which
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cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) to produce diacyl glycerol (DAG) and
the second-messenger inositol 1,4,5-triphosphate (IP3). In turn, IP3 diffuses into the cytosol
and agonizes IP3-gated ion channels on the ER surface, causing an increase in cytosolic Ca
2+
concentration. Gα12/13 is implicated mostly in such processes as actin remodeling and cellular
migration. The Gβγ dimer lacks a catalytic domain and acts through regulated protein-protein
interactions [84]. Although the list of Gβγ-interacting proteins continues to grow, Gβγ signal-
ing is generally treated as a secondary signaling pathway with respect to Gα-mediated signaling.
Figure 1.2 presents an overview of the primary GPCR signaling pathways and the endpoints
most frequently assayed as a function of GPCR activation.
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Figure 1.2 GPCR signal transduction.
The three primary G protein subtypes (G-αs, G-αi and G-αq) are depicted along with their
corresponding intracellular signaling pathways. The biochemical endpoints most commonly
monitored in studies of GPCR activation are cAMP and Ca2+.
More recent findings have further nuanced our understanding of GPCR structure and signaling.
A growing body of biophysical studies indicate the presence of functional receptor dimers
and higher order oligomers in Rhodopsin GPCRs with varying symmetries [85, 86]. While
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examples of obligate homo- and hetero-dimerization have long existed for Glutamate family
GPCRs [87], this represents a significant challenge to the classical view of receptor monomers as
the functional signaling unit for the numerically dominant Rhodopsin family. Despite ambiguity
as to the scale of occurrence, the possibility of widespread oligomeric signaling necessitates the
development of more sophisticated pharmacological and regulatory models to describe receptor
behavior [88].
1.5.2 Export and Regulation
GPCR synthesis, folding, and assembly occur at the ER. The underlying mechanisms of GPCR
transport from the ER to the cell surface are not yet very well understood, at least in com-
parison to the extensive work performed on the endocytic pathway. Proper folding has been
shown to involve the guidance of ER chaperones and accessory proteins [89]. Further, proteins
such as receptor activity modifying proteins (RAMPs) can affect the pharmacology of eventual
surface-exposed receptors [90]. Correctly-folded receptors which are able to pass the ER quality
control mechanism are packaged into ER-derived vesicles for export. GPCR motifs have been
identified that play a role in ER export regulation by selective interaction with components of
the COPII transport system, influencing such parameters as cargo concentration and rate of
exit [91]. GPCRs are transported in vesicles to the cell surface through the ER-Golgi inter-
mediate complex (ERGIC), the Golgi, and the trans-Golgi network (TGN). Along the export
pathway, the vast majority of GPCRs undergo some form of post-translational modification
(e.g., palmitoylation and glycosylation) [92].
G protein export follows along similar lines, with both co- and post-translational modifications
helping establish the physical association of G protein subunits with the cell membrane. Except
in the case of Gαt, all Gα subunits are N-terminally palmitoylated [81]. Gαi subunits are also
targets of N-terminal myristoylation. Although the Gβγ dimer exhibits greater hydrophobicity,
this is insufficient for membrane association and Gγ subunits undergo C-terminal thio-ether-
linked isoprenylation with either a farnesyl or geranylgeranyl moeity [93]. Once GPCRs and
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G proteins have made their way to the cell surface, they are known to interact with molecules
such as GRKs (GPCR kinases) [94, 95], arrestins [96, 97], and RGS (regulators of G protein
signaling) proteins such as GAPs (GTPase-activating proteins) [98, 99]. These cellular actors
regulate receptor internalization, coupling, ligand binding, recruitment and recycling.
The activation cycle of heterotrimeric G proteins can be described by the equilibrium of active
Gα*[GTP] and inactive Gα[GDP] subunits. GPCRs in their active conformation act as GEFs,
promoting Gα GDP release and the rapid binding of GTP: [GTP]cytosol  [GDP]cytosol. There
are two basic models that describe G protein-GPCR interactions [93]. In the ‘collision cou-
pling’ model, G proteins associate with active GPCRs as a result of free stochastic movement
within the membrane. In the ‘pre-coupling’ model, G proteins are coupled to GPCRs prior to
their activation. Antagonistic to receptor-mediated GEF activity, Gα subunits have intrinsic
GTPase activity. This reaction is catalyzed by GAPs, which significantly accelerate the rate of
GTP hydrolysis and thus, signal termination.
Gα[GDP]Gβγ
GEF−−−⇀↽−−−
GAP
G∗α[GTP] + Gβγ
To modulate the magnitute and specificity of intracellular biochemical responses to extracel-
lular ligands, receptors are tightly regulated. The best-characterized pathway for receptor
downregulation is the endocytic pathway via clathrin-coated pits (CCPs) [97, 100]. In this
pathway, the intracellular domains of agonist-occupied GPCRs are phosphorylated by GRKs,
followed by arrestin binding. Arrestin brings about receptor desensitization by inhibition of G
protein coupling. Receptor/arrestin complexes can be recruited through an adapter complex
into clathrin-coated pits, resulting in receptor internalization and the formation of the early
endosome. Receptors are then sorted, either marked for lysosomal destruction or recycled back
to the cell surface.
Another mechanism of homologous desensitization involves the activity of enzymes accumulated
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downstream of G protein activation, such as protein kinase A (PKA) and protein kinase C
(PKC) [101]. These enzymes can directly or indirectly (through GRKs) phosphorylate agonist-
bound GPCRs. Alteration of the coupling profile of a receptor is another potential consequence
of phosphorylation [102]. The molecular events governing heterologous desensitization are less
well understood [103], however, it should be noted that receptor signaling pathways can exhibit
extensive cross-talk leading to positive or negative forms of regulation [104].
1.5.3 Phylogenetic Overview
Early efforts to sub-classify and bioinformatically fingerprint the GPCR superfamily gave rise
to the A-F classification system [105, 106]. Pharmacological organization of this receptor fam-
ily was continued with the GPCRDB database [107]. More recent phylogenetic analysis of
the entire known human GPCR complement revealed five primary GPCR groupings: Gluta-
mate, Rhodopsin, Adhesion, Frizzled and Secretin [108]. Together, the families are referred to
as ‘GRAFS’, and their lineages have been shown to extend throughout the metazoa [109, 110]
(Table 1.3). Within-family phylogenetic analysis of Rhodopsin GPCRs revealed four primary
clusters (α, β, γ, and δ), further sub-classified into 13 groups.
H. sapiens M. musculus D. melanogaster C. elegans
G 24 112 9 6
R 752 1106 76 124
A 27 13 5 5
F 10 11 7 5
S 20 28 13 5
Table 1.3 GRAFS species comparison.
Among these, the α amine and β peptide groupings are the most populated in most examined
species, including the Ecdysozoa. Many of these Rhodopsin sub-groupings are only present in
mammals, and examples of lineage-specific GPCR expansions can also be identified that fall
outside this classification scheme. For example, nematode chemosensory receptors in C. elegans
comprise over 85% of the total GPCR complement [111]. Flatworm whole genome sequence
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data provides an important substrate for the potential identification of similar phylum or
species-specific GPCR groupings.
1.6 In silico GPCR Mining
Growing genomic resources have provided a GPCR mining platform for a number of organ-
isms, including Homo sapien [112], Mus musculus [113], Gallus gallus [114], Rattus rattus [115],
Tetraodon nigrovirdis [116], Anopheles gambiae [117], Drosophila melanogaster [118], Ciona
intestinalis [119], Branchiostoma floridae [120], Xenopus tropicalis [121] and Canis famil-
iaris [122]. GPCR sequences have been accumulated in these genomes using a range of bioin-
formatics methods that include homology-based searching (BLAST), hidden Markov models
(HMMs) and motif-driven queries [123]. The more successful GPCR mining protocols have
involved the application of a combination of such methods and algorithms.
Known GPCR sequences are commonly used as queries to search against sequence assemblies
with BLAST [124]. BLAST is a heuristic that approximates the optimal Smith Waterman align-
ment algorithm, allowing for efficient searches against large genomic datasets. This algorithm
is ideal for finding sequences that share at least moderate sequence similarity, but is limited in
its ability to detect highly-diverged or novel GPCR sequences. While BLAST identifies global
sequence homology, motif-based approaches focus on highly-conserved and length-restricted
aspects of GPCR primary structure. The ordered combination of motifs in the form of finger-
prints can be used to filter false positives generated by individual motifs. While motifs can be
declared with different levels of exactness, this approach suffers from similar disadvantages in
the detection of atypical GPCR sequences.
Profile hidden Markov models (HMMs) represent a more sophisticated alignment-based ap-
proach to the modeling of protein families. In broad terms, a hidden Markov model consists
of a system of ‘hidden’ states and observed variables. Conditional probabilities are ascribed
to state transitions, as well as for the emission of variables within states. In the biological
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application of HMMs, emmitted variables are typically sequence alphabets (e.g. nucleotide or
amino acid) and hidden state paths represent underlying biological units (e.g. introns or GpC
islands) [125]. Profile HMMs have been introduced as a means of building consensus statis-
tical models of protein familities [126]. The underlying architecture of these HMMs consists
of a ‘match’, ‘insert’, and ‘delete’ state, fit for linear sequence data. Profile HMMs have seen
extensive use in GPCR discovery, and HMMs have also been developed for the prediction of
G protein coupling profiles [127], TM domain boundaries [128, 129], and the identification of
peptide ligands [130].
1.7 In silico GPCR Classification
GPCR
Frizzled SecretinAdhesionRhodopsinGlutamate
Peptide Amine Hormone (Rhod)opsin ...
Level 1 (Family)
Level 2 (subfamily)
Superfamily
Acetylcholine Dopamine Histamine Serotonin ...Level 3 (sub-subfamily)
HMM
SVM
SVM
Figure 1.3 GPCR classification tree.
GRAFS-based distinctions are presented at the family (level 1) plane, while consensus classification
shared between the A-F and GRAFS systems are used at the subfamily (level 2) and sub-subfamily
(level 3) plane. Profile HMMs can be used to effectively distinguish GPCRs from other transmembrane
proteins and to place them within their primary families. SVM classifiers can be used for level 2 and 3
placement of Rhodopsin family GPCRs.
There is great overlap in the computational approaches to GPCR mining and GPCR classifi-
cation, and the methods discussed above can be applied to both. While HMMs are adequate
for GPCR identification and classification at the family plane, other algorithms outperform
HMM and homology-based classifiers at deeper classification planes (Figure 1.3). Numerous
support vector machine (SVM) classifiers have been shown to classify GPCRs with high accu-
racy at the subfamily and sub-subfamily levels. In reduced terms, SVMs represent a powerful
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supervised-learning method for data classification. Given a combined set of positively and
negatively labeled training instances, an SVM produces a binary classifier that can then be
used to label unknown samples. Each instance is associated with a fixed-length numerical fea-
ture vector, containing certain attributes of the data to be classified. The SVM identifies a
maximum-margin separating hyperplane to distinguish between vectors representing instances
of opposite sign (Figure 1.4, [131]).
SVM training datasets are populated by pairings of feature vectors and classification groups:
Dataset = {xi, yi} | xi ∈ <D, yi ∈ {−1,+1} (1.1)
where i = 1, ..., n and n represents the number of training instances
where D represents the dimensionality of feature vectors used in training
In the linear case, the SVM identifies a hyperplane of the form:
w⊥x+ b = 0 (1.2)
where w is the normal vector perpendicular to the hyperplane
We can select normalization such that
w⊥x+ b ≥ +1 (1.3)
w⊥x+ b ≥ −1 (1.4)
for positive (+1) and negative (−1) support vectors, respectively
The margin between these is given by 2/‖w‖, and an SVM can be trained to maximize this
distance by minimizing ‖w‖. This is treated as a quadratic optimization problem with linear
constraints [131]. Data that is not fully linearly separable is dealt with by the introduction of
slack variables that introduce costs for misclassified instances. Additionally, non-linearly sep-
arable feature vectors must often be mapped to a higher dimensional space by the application
19
of kernel functions. The kernel trick allows for the construction of a separating hyperplane in
the transformed feature space.
9
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|w|
w
Origin
Margin
H1
H2
Figure 5. Linear separating hyperplanes for the separable case. The support vectors are circled.
Thus, we introduce positive Lagrange multipliers αi, i = 1, · · · , l, one for each of the
inequality constraints (12). Recall that the rule is that for constraints of the form ci ≥ 0,
the constraint equations are multiplied by positive Lagrange multipliers and subtracted
from the objective function, to form the Lagrangian. For equality constraints, the Lagrange
multipliers are unconstrained. This gives Lagrangian:
LP ≡ 1
2
‖w‖2 −
l∑
i=1
αiyi(xi ·w+ b) +
l∑
i=1
αi (13)
We must now minimize LP with respect to w, b, and simultaneously require that the
derivatives of LP with respect to all the αi vanish, all subject to the constraints αi ≥ 0
(let’s call this particular set of constraints C1). Now this is a convex quadratic programming
problem, since the objective function is itself convex, and those points which satisfy the
constraints also form a convex set (any linear constraint defines a convex set, and a set of
N simultaneous linear constraints defines the intersection of N convex sets, which is also
a convex set). This means that we can equivalently solve the following “dual” problem:
maximize LP , subject to the constraints that the gradient of LP with respect to w and b
vanish, and subject also to the constraints that the αi ≥ 0 (let’s call that particular set of
constraints C2). This particular dual formulation of the problem is called the Wolfe dual
(Fletcher, 1987). It has the property that the maximum of LP , subject to constraints C2,
occurs at the same values of the w, b and α, as the minimum of LP , subject to constraints
C18.
Requiring that the gradient of LP with respect to w and b vanish give the conditions:
w =
∑
i
αiyixi (14)
∑
i
αiyi = 0. (15)
Since these are equality constraints in the dual formulation, we can substitute them into
Eq. (13) to give
LD =
∑
i
αi − 1
2
∑
i,j
αiαjyiyjxi · xj (16)
Figure 1.4 SVM classification: the linear case.
Recently, this approach has seen extensive use in the area of biosequence discrimination, and
relevant to our goals, the particular problem of GPCR classification. In the first study on
the matter, SVM-based classifiers were shown to drastically outperform their BLAST and
HMM-based counterparts for level 1 and level 2 GPCR subclassification [132]. Subsequent
studies further improved the predictive performance of SVMs with the introduction of dipep-
tide composition feature vectors [133, 134], achieving accuracies of 97.3% and 96.4% for level
1 (Rhodopsin) and level 2 (amine) classification, respectively. Alternative feature vectors have
since been similarly validated [135,136].
Although SVMs are binary classifiers, they can be applied to multi-class problems where the
number of classes, k, is greater than 2. Such problems are typically solved using either the
“one-versus-rest” (OvR) or “one-versus-one” (OvO) method. In the OvR scenario, k binary
classifiers are trained, such that each classifier separates one class from all others. The “winner-
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takes-all” strategy is then commonly used to label unknown samples, whereby the classifier with
the highest output decision function assigns the final class. In the OvO scenario, k(k−1)2 binary
classifiers are constructed in a pair-wise manner. A voting strategy is then typically employed
in classification, whereby each classifier accounts for one vote and the class with the maximum
number of votes assigns the final label. Although the OvO method has been shown to perform
better on a number of fronts [137], as far as the authors are aware, all previously described
SVM-based GPCR classifiers available for public use rely on the simpler OvR method.
1.8 GPCR Deorphanization
Once identified, GPCRs require deorphanization, the process of pairing orphan receptors with
their cognate ligands. The predominant approaches all require the transient or stable heterolo-
gous expression of receptors in a surrogate cell system and in most cases, this expression occurs
in cells derived from other species and phyla. In the absense of a flatworm cell culture line,
flatworm GPCRs have been expressed in such divergent cellular environments as CHO [138],
HEK293 [139,140], COS7 [139], yeast [140,141], and Xenopus oocyte cells [142]. The traditional
work-flow begins with full-length sequence cloning and introduction of the receptor coding se-
quence into an appropriate expression vector designed for the particular cell culture system.
Receptor activation assays incorporate different detection schemes (e.g. fluorescence, biolumi-
nescence, and gene reporting) and are amenable to a host of receptor-specific adaptations. In
mammalian cell culture, GPCR activation is commonly assayed as a function of Ca2+ mobiliza-
tion from the ER (Figure 1.5). Agonist-evoked calcium flux can be detected using fluorescent
calcium-sensitive dyes in a high throughput platform. In this system, co-transfected G protein
chimeras [143, 144] can be used to divert GPCR signaling through the Gαq pathway, irrespec-
tive of the endogenous receptor coupling profile. The carboxyl-terminus of the Gα subunit is
primarily responsible for receptor specificity, and chimeric G proteins have been constructed
via replacement of the five C-terminal amino acids of Gαq alpha with those of other G protein
subtypes.
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Figure 1.5 GPCR deorphanization in mammalian culture.
Yeast have also been shown to be attractive heterologous GPCR expression systems for a num-
ber of reasons. They provide a minimal eukaryotic host environment, are genetically robust and
amenable to manipulation, and are low cost and relatively easy to maintain in the laboratory.
Further, they lend themselves to high throughput-screening assays with simple outputs. A
number of yeast strains have been genetically modified for the purpose of heterologous GPCR
expression. In these engineered strains, modifications of the endogenous yeast GPCR-mediated
pheromone response pathway direct the activation of a non-native GPCR to yeast growth as
a phenotypic output [145]. Our laboratory and others have had recent success in employing
yeast as a means of deorphanizing both platyhelminth [140] and nematode [146] GPCRs, and
we have continued on this path with other flatworm receptors (Appendix B).
1.8.1 Difficulties and Pitfalls
Current approaches to GPCR deorphanization have severe limitations and are inefficient for
large-scale projects. This has introduced a significant bottleneck in the way of both the pharma-
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cological and structural characterization of GPCRs [147,148]. Although heterologous expression
is not a theoretically challenging feat, individual targets routinely prove to be recalcitrant and
consume inordinate effort. The time and effort required to establish the transient or stable
expression of a receptor make traditional approaches undesirable for projects of larger scale.
The processes that guide the proper folding and export of receptors are not necessarily well-
conserved across cell lineages. Further, a significant set of potential concerns also present
themselves post-transfection or transformation. In the event that a GPCR is successfully ex-
pressed on the surface of a host cell, the GPCR must operate in conjunction with a foreign
complement of accessory and signaling proteins. The possibility of a receptor with altered
structure or function is therefore a consequential worry. In view of these concerns, a receptor
deorphanization method that could be applied in a native cell or membrane environment could
side-step some of these concerns.
1.9 General Objectives
Objective 1. Whole-genome identification and classification of GPCRs in S. mansoni and S.
mediterranea using a transmembrane-focused bioinformatics protocol. The primary hypothesis
is that these platyhelminths possess an extensive and complex GPCR repertoire, and exhibit
a host of lineage-specific features.
Objective 2. Development of a loss-of-function GPCR deorphanization protocol that occurs
in the native cell membrane environment. The primary hypothesis is that joining RNAi and
GPCR second messenger assays can lead to the elucidation of receptor agonists and G protein
coupling pathways.
These objectives are pursued with the overarching goals of identifying schistosome drug targets,
mapping platyhelminth receptor biology, promoting planarians as model organisms for parasite
research, and establishing higher-throughput methods of receptor deorphanization and drug
target validation. The selection of specific ‘rational’ targets is aided by these focused objectives.
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2 The Repertoire of G Protein-Coupled Receptors in the Human Parasite
Schistosoma mansoni and the Model Organism Schmidtea mediterranea
A paper submitted to the Journal BMC Genomics
Mostafa Zamanian 1,2,∗, Michael J Kimber 1,2, Paul McVeigh 3, Steve A Carlson 1,2, Aaron G
Maule 3, Tim A Day 1,2,∗
Abstract
Background: G protein-coupled receptors (GPCRs) constitute one of the largest groupings of
eukaryotic proteins, and represent a particularly lucrative set of pharmaceutical targets. They
play an important role in eukaryotic signal transduction and physiology, mediating cellular
responses to a diverse range of extracellular stimuli. The phylum Platyhelminthes is of con-
siderable medical and biological importance, housing major pathogens as well as established
model organisms. The recent availability of genomic data for the human blood fluke Schis-
tosoma mansoni and the model planarian Schmidtea mediterranea paves the way for the first
comprehensive effort to identify and analyze GPCRs in this important phylum.
Results: Application of a novel transmembrane-oriented approach to receptor mining led to
the discovery of 116 S. mansoni GPCRs, representing all of the major families; 104 Rhodopsin,
2 Glutamate, 3 Adhesion, 2 Secretin and 5 Frizzled. Similarly, 291 Rhodopsin, 9 Glutamate,
21 Adhesion, 1 Secretin and 11 Frizzled S. mediterranea receptors were identified. Among
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these, we report the identification of novel receptor groupings, including a large and highly-
diverged Platyhelminth-specific Rhodopsin subfamily, a planarian-specific Adhesion-like family,
and atypical Glutamate-like receptors. Phylogenetic analysis was carried out following extensive
gene curation. Support vector machines (SVMs) were trained and used for ligand-based clas-
sification of full-length Rhodopsin GPCRs, complementing phylogenetic and homology-based
classification.
Conclusions: Genome-wide investigation of GPCRs in two platyhelminth genomes reveals
an extensive and complex receptor signaling repertoire with many unique features. This work
provides important sequence and functional leads for understanding basic flatworm receptor
biology, and sheds light on a lucrative set of anthelmintic drug targets.
2.1 Background
The G protein-coupled receptor (GPCR) superfamily constitutes the most expansive family of
membrane proteins in the metazoa. These cell-surface receptors play a central role in eukary-
otic signal transduction, and conform to a structural archetype consisting of a core domain
of seven transmembrane (TM)-spanning α-helices. GPCRs are also established drug targets,
acting as sites of therapeutic intervention for an estimated 30-50% of marketed pharmaceuti-
cals [79, 149]. This is undoubtedly a function of their extensive involvement in a wide range
of important physiological processes. The diverse panel of known GPCR ligands includes bio-
genic amines, photons, peptides, odorants and classical neurotransmitters [80]. This diversity
is mirrored by the significant degree of primary sequence variation displayed among GPCRs.
At present, there exists no comprehensive study of GPCRs for the phylum Platyhelminthes.
This important phylum houses prominent endoparasites, both flukes and tapeworms, as well as
free-living species that serve as established model organisms in the realm of developmental bi-
ology. Lack of sequence data and a reliance on techniques with a definably narrow expectation
of success such as degenerate PCR have contributed to the very modest number of GPCRs thus
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far identified or characterized [138–140,142,150,151] in this phylum. The arrival of EST repos-
itories [49,152,153] has only marginally contributed to this number, perhaps as a consequence
of GPCR under-representation [154]. The recent availability of Schistosoma mansoni [24] and
Schmidtea mediterranea [27] whole genome sequence data provides basis for the in silico accu-
mulation and analysis of undiscovered and potentially novel receptors.
The blood fluke Schistosoma mansoni is the primary etiological agent of human schistosomi-
asis, a chronic and debilitating condition that aﬄicts a staggering 207 million people in 76
countries [2] and accounts for 280,000 deaths per annum in sub-Saharan Africa alone [155].
It is calculated that up to 70 million disability-adjusted life years (DALYs) are lost to schis-
tosomiasis annually [4]. This figure surpasses the global burden posed by both malaria and
tuberculosis, and is nearly equivalent to that of HIV/AIDS. At present, this overwhelming
disease burden is met with a near exclusive reliance on treatment with the drug praziquantel.
The threat of drug resistance [9,10] has spurred recognition of the pressing need for new antis-
chistosomals [1,13,15]. In this context, as modulators of a diverse range of critical biochemical
and physiological pathways, GPCRs hold great promise as potential targets for disruption of
crucial parasite survival and proliferation activities.
The free-living planarian Schmidtea mediterranea is an important platyhelminth studied exten-
sively for its regenerative abilities [17,156]. Like other planarians, it is abundantly seeded with
totipotent stem cells with the ability to migrate and undergo division and differentiation at sites
of injury. In addition to its current role as a powerful model organism for regeneration and stem
cell biology, S. mediterranea presents itself as a potential parasite drug discovery model [157].
In the case of nematodes, the biology of the free-living model organism Ceanhorhabditis elegans
features prominently in many anti-parasitic drug discovery efforts [158, 159]. Like C. elegans,
S. mediterranea is significantly more tractable to modern genomic approaches compared to the
parasitic members of its phyla. It is relatively easy to maintain and it is amenable to RNA
interference (RNAi) [71]. Genome-wide analysis and comparison of the GPCR complements of
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S. mansoni and S. mediterranea is a major step towards engaging this hypothesis.
The growing number of sequenced genomes has provided a GPCR mining platform for a number
of organisms, including Homo sapien [112], Mus musculus [113], Gallus gallus [114], Rattus rat-
tus [115], Tetraodon nigrovirdis [116], Anopheles gambiae [117], Drosophila melanogaster [118],
Ciona intestinalis [119], Branchiostoma floridae [120], Xenopus tropicalis [121] and Canis fa-
miliaris [122]. For these organisms, GPCR sequences have been accumulated with a range of
bioinformatic methods that include homology-based searching (BLAST), hidden Markov mod-
els (HMMs) and motif-driven queries [123]. The more sophisticated GPCR mining protocols
have involved the application of a combination of such methods and algorithms.
Phylogenetic studies of the GPCRs in a number of eukaryotic genomes have led to the introduc-
tion of the GRAFS classification system [108,109]. GRAFS outlines five major protein families
thought to represent groupings of receptors with shared evolutionary ancestry present in the
Bilateria: Glutamate, Rhodopsin, Adhesion, Frizzled, and Secretin. In addition to these primary
families, some organisms are known to house groupings of lineage-specific receptors that con-
stitute distinct GPCR families. Examples in the phylogenetic vicinity of the Platyhelminthes
include the nematode chemosensory receptors [160] and insect gustatory receptors [161]. Any
in silico protocol for genome wide GPCR identification should therefore cast a broad enough
net to reveal any such highly-diverged receptor groupings, while also providing stringency to
limit false positives.
Here, we apply an array of sensitive methods towards the goal of identifying, manually curating
and classifying putative G protein-coupled receptor sequences in two prominent platyhelminths.
Our hypothesis is that organisms in this phylum possess an extensive and complex complement
of GPCRs, including phylum or species-specific GPCR groupings. We perform phylogenetic
analysis of putative receptors with respect to the GRAFS classification system and employ a
machine-learning approach for ligand-based classification of full-length Rhodopsin GPCRs.
27
2.2 Results and Discussion
In this study, we developed a robust transmembrane-focused strategy to identify, curate and
classify putative platyhelminth GPCRs. TM-focused profile hidden Markov models (HMMs)
were used to mine the predicted proteomes of S. mansoni and S. mediterranea in order to iden-
tify receptors at the GPCR family plane. Subsequent rounds of filtering were used to remove
false positives, followed by homology-based searches against the original genome assemblies.
Extensive manual curation of the final sequence dataset allowed for more refined phylogenetic
analysis. Greater classification depth was achieved with a complementary transmembrane-
focused support vector machine (SVM)-based classifier. An overview of this bioinformatics
protocol is outlined in Figure 2.1.
Identification of GRAFS family receptors with TM-focused profile HMMs
Towards the goal of identifying members of the GRAFS GPCR families in our genomes of
interest, we relied primarily on the use of family-specific profile HMMs. This alignment-rooted
method has been successfully applied in other genomes and has been shown suitable for the
identification and classification of GPCR sequences at the family level [123, 162]. In a depar-
ture from previously described protocols, we chose to focus HMM training exclusively on the
most highly-conserved structural features that extend throughout the GPCR superfamily. The
idea behind this measure was to dampen challenges posed by the inexact gene structures that
underlie the flatworm predicted proteomes, as well as the sizable phylogenetic distance of this
phylum from organisms with characterized GPCR complements.
In this framework, receptor transmembrane domains are convenient markers that can be
identified with greater confidence than other GPCR stretches using sensitive prediction al-
gorithms such as HMMTOP [128] and TMHMM [129]. Training sequences were procured
from GPCRDB [107] and processed into what we will refer to as “transmembrane-only pseu-
dosequences” (TOPs), representing the ordered concatenation of TM domains flanked bi-
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directionally by 5 amino acids (Figure 2.1b). TM-focused HMMs were constructed for each
of the major GPCR families, as well as for the nematode chemosensory and insect odorant
families. The Adhesion and Secretin training sets were combined to build a single HMM, given
that sequences belonging to these families are not easily distinguishable beyond the N-terminal
ectodomain [154].
The predicted proteomes of S. mansoni and S. meditearranea were first filtered for the removal
of globular proteins. Typical strategies limit investigation to proteins with 6-8 predicted TM
domains, tolerating errors in the algorithmic prediction of these regions. We significantly re-
laxed this filter and broadened the search scope to include all proteins with 3-15 TM domains.
The utility of this change then was to alert us to partial sequences or incorrectly predicted gene
models that may be reconstructed with manual curation and that otherwise would have been
screened from detection. Family-derived profile HMMs already provide an adequately stringent
filter for distinguishing between GRAFS family receptors and other transmembrane proteins.
The proteins that survived this filter were processed into TOPs in the same manner as the
training sequences. These sequences were searched against the set of profile HMMs, and the
resulting hits for each GPCR family were ranked according to E-value. A primary cut-off
was selected at the point where subsequent hits showed significant homology to other known
proteins or GPCRs belonging to other families. This was accomplished with a BLASTp [124]
search of all hits against the NCBI non-redundant (nr) database. Sequences that displayed
GPCR-related homology, along with those that returned no significant BLAST results, were
retained. As evidenced later, the requirement of statistically meaningful GPCR-related ho-
mology introduces an unnecessary selection bias that can mask the identification of unique
receptors.
Application of the Rhodopsin HMM to the S. mansoni predicted proteome led to the examina-
tion of the 400 top-ranking hits (E-value < 0.007), 77 of which remained after removal of false
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positives via homology-based searches. Similarly, 270 of the 450 top-ranked (E-value < 0.002)
Rhodopsin HMM hits remained for S. mediterranea. Redundancy within the S. mediterranea
genome assembly warranted the detection and removal of identical sequences. BLAT [163] was
used to self-align the nucleotide sequences of the predicted proteins that survived the HMM
filtering process. Redundant sequences were removed and if a choice was presented, the longest
member of a set of identical sequences was retained. This led to the removal of 14 Rhodopsin
sequences from the S. mediterranea dataset. Figure 2.2 displays the overall transmembrane
distribution for both proteomes at these various stages of processing for the Rhodopsin family.
These steps were likewise performed for the nematode chemosensory and insect odorant GPCR
families, however no flatworm orthologs were identified. This is not unexpected, considering
their lack of conservation among the Ecdysozoa.
Manual editing of gene models
Candidate GPCR sequences underwent manual inspection, and the corresponding gene models
were edited. This labor-intensive step is crucial in improving the reliability of any further
analysis on this gene family. Common manual edits included the merging or splitting of gene
models, movement of intron-exon boundaries, and sequence extension or truncation in either or
both directions. This process was aided by examination of open reading frames (ORFs) in the
vicinity of a gene models. ORFs that housed common receptor motifs, displayed GPCR-related
homology or contained transmembrane stretches were typically incorporated. In many cases,
sequencing gaps prevented any meaningful improvement. S. mansoni GRAFS sequences and S.
mediterranea GAFS sequences were curated in this manner. We avoided genome-wide manual
curation of S. mediterranea Rhodopsin sequences in light of the dubious condition of the draft
genome. The A/T rich (69%), highly repetitious (46%) and heterozygous nature of the genome
has significantly complicated automated assembly efforts. However, as we elaborate later,
we did construct and edit gene models for a particular grouping of Rhodopsin-like Schmidtea
GPCRs. The significant level of improvement achieved by manual gene editing is shown in
Figure 2.3.
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Homology-based search and final gene editing
To account for the likelihood that the primary sets of gene models used do not provide per-
fect accounting of all gene-encoding regions within the assemblies, we exercised a translated
nucleotide BLAST (tBLASTn). For each family, putative GPCRs were combined from both
species and searched locally against the original nucleotide assemblies translated in all six
frames. Hits with E-value < 0.1 were manually examined for GPCR-related homology. In
cases where identified regions of homology overlapped with a given gene model, that gene
model was added to the sequence pool. Conversely, if no gene model was found to be present
at a particular genomic location, a simple preliminary gene model was built by connecting the
high-scoring segment pairs (HSP) that contributed to the tBLASTn hit. In keeping with the
HMM approach, only putative receptors with a TM count ≥ 3 were retained. This led to a
further significant expansion of the total unique sequence count in both organisms (Table 2.1).
This reported sequence count is not equivalent to a receptor count, as many of these sequences
may represent fragments of a single protein or prove to be redundant sequences. To bridge this
gap and to improve the general state of this additional sequence data, manual editing of gene
models was again performed.
Overall phylogenetic view
Putative receptor sequences were tentatively divided into three sequence bins based on the
number of predicted TM domains: full-length, near full-length and partial. Full-length se-
quences were those that likely had their entire 7TM domain intact as predicted by HMMTOP
with user oversight. Alignments to homologous proteins were used to help make a final deci-
sion with respect to the potential algorithmic miscounting of TM domains. Near full-length
sequences are predicted to contain ≥ 4 TM domains, while all other sequences (< 4 TM do-
mains) were placed into the partial sequence bin. Phylogenetic analysis was carried out for
full-length and many near full-length receptors. Figure 2.4 displays a topological overview
of the primary flatworm GPCR groupings. This phylogenetic analysis confirms the distinct
and analogous presence of the primary GRAFS families, and further reveals two novel flat-
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worm GPCR families: Platyhelminth-specific Rhodopsin-like orphan family 1 (PROF1) and
Planarian Adhesion-like receptor family 1 (PARF1).
The Rhodopsin family
The Rhodopsin family is divided into four main groups (α, β, δ, and γ) and further subdivided
into 13 major sub-families via analysis of fully sequenced mammalian genomes [110]. The α and
β subfamilies are well-populated in both S. mansoni and S. mediterranea (Figure 2.5), while
the δ and γ subfamilies are absent. Table 2.2 provides a preliminary classification of receptors
identified with respect to the GRAFS classification system from a comparative perspective.
Alpha (α) receptors
The α subfamily houses amine, opsin-like, and melatonin receptors. Among these, the amine
grouping is typically largest. This metazoan trend holds true for S. mansoni and S. mediter-
ranea, each possessing at least 25 and 60 putative aminergic receptors, respectively. These
numbers are greater than those observed among ecdysozoans, and in the case of S. mediter-
ranea, the figure surpasses even the human amine GPCR complement. Biogenic amines such
as serotonin (5-hydroxytryptamine; 5HT), dopamine, and histamine have been shown to play
a prominent role in the flatworm nervous system [164,165]. Although a small number of amin-
ergic GPCRs have been characterized in this phylum, the majority of receptors that mediate
aminergic signaling have thus far remained elusive. Phylogenetic analysis was carried out on the
flatworm amine GPCR complement with respect to C. elegans aminergic receptors, as shown
in Figure 2.6. Two diverged flatworm-specific groupings can be outlined, including one that
signifies a major paralogous expansion in schistosomes. Other flatworm receptors are grouped
and tentatively associated with ligands corresponding to their phylogenetic relationships with
deorphanized C. elegans GPCRs.
Four melanopsin-like receptors were identified in S. mansoni. Five melanopsin-like receptors
were identified in S. mediterranea, along with a single receptor that displays moderate homology
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to various ciliary opsins. Along with the presence of cyclic nucleotide gated (CNG) ion chan-
nels in the planarian genome, this raises the possibility of ciliary phototransduction. Another
noteworthy observation is the conspicuous absence of melatonin-like receptors in S. mansoni,
while S. mediterranea houses a relatively large complement of 9 such receptors. Melatonin is
endogenously synthesized in planaria in a circadian manner [166,167], and has been implicated
in regeneration [168]. Identification of melatonin receptors is a requisite for a more complete
mapping of the underlying signal transduction pathway(s) in these important processes.
Beta β receptors
The β subfamily contains the great majority of peptide and peptide hormone GPCRs in exam-
ined organisms. Neuropeptidergic signaling is known to play a fundamental role in flatworm
locomation, reproduction, feeding, host-finding and regeneration [169, 170]. The known flat-
worm neuropeptide complement has recently undergone considerable expansion with the appli-
cation of bioinformatics and mass spectrometry-based (proteomics) approaches [171,172]. This
represents a significant advance from the original handful of FMRFamide-like peptides (FLPs)
and neuropeptide Fs (NPFs) first identified in the phylum. Many of these newly-identified
amidated peptides are planarian or flatworm-specific, while others exhibit relatedness to pep-
tides in other phyla, including myomodulin-like, buccalin-like, pyrokinin-like, neuropeptide FF
(NPFF)-like, and gonadotropin (or thyrotropin) releasing hormone-like peptides.
Our efforts yielded at least 81 and 35 putative peptide receptors in S. mediterranea and S.
mansoni, respectively. These numbers further evidence the notion that peptidergic signaling
is the predominant mode of neurotransmission in the Platyhelminthes. Flatworm peptide re-
ceptors do not cluster into a single phylogenetic group (Figure 4b). One groupings contains
GPCRs that share homology with receptors responsive to peptide ligands present in the ver-
tebrate lineage, while the other is mostly populated with receptors that share homology with
invertebrate neuropeptide-responsive receptors including Gt-NPR1 homologs. It can be noted
that the putative flatworm peptide receptor count greatly outnumbers the set of currently
33
known peptide ligands. Although this may be explained by peptide promiscuity and receptor
redundancy, it is also very possible that many neuropeptides have yet to be uncovered. Ligands
cannot be confidently assigned to the majority of identified receptors. While some show mod-
erate homology to characterized FLP and NPF-like receptors, most receptors display weak or
insignificant homology to an assortment of thyrotropin-releasing hormone, capa, sex peptide,
growth hormone secretagogue, proctolin, pyrokinin, myokinin, tachykinin, galanin, and orexin
receptors. These tentative BLAST-based annotations may be used with caution to help guide
receptor deorphanization efforts.
Other receptors
A large number of Rhodopsin receptors could not be individually annotated with confidence, and
were placed in the “Other Rhodopsin” receptor bin. Receptors in this category lack phylogenetic
support to be clustered with known Rhodopsin groupings, and lack meaningful homology to
receptors with known ligands. Many receptors in this bin exhibit some weak peptide or amine
receptor-relatedness, but these require functional validation before they can be added to the α
or β subfamily counts. Many of these receptors are likely unique to the phylum, and therefore
obscure the Rhodopsin family subdivisions apparent in the vertebrate lineage.
Planarian homologs of parasite GPCRs
Given the relative tractability of planarians to experimental manipulation, we identified the
nearest homologs of S. mansoni Rhodopsin receptors in the S. mediterranea pool (Tables 2.3
- 2.5). It is a reasonable expectation that there is significant conservation in the biological and
pharmacological properties of receptors sharing high sequence identity between these species.
The characterization of certain planarian receptors is likely to inform us about the function
and druggability of parasite receptors. Each S. mansoni receptor was first matched to its
most similar S. mediterranea sequelog, and sequence pairs were ranked according to amino acid
percent identity (PID): 8 receptor pairs were identified sharing > 50% PID, 15 with 40-50%
PID, 48 with 30-40% PID, and the remaining sequences with < 20% PID. The top grouping is
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comprised exclusively of biogenic amine (GAR and 5HT) and peptide GPCRs. Among them is
a receptor pair orthogolous to Gt-NPR1 [139], the only neuropeptide receptor deorphanized in
this phylum. This degree of sequence conservation promotes the use of planaria as a convenient
heterologous system to study parasite receptors.
Platyhelminth-specific Rhodopsin-like orphan family 1 (PROF1)
A large and distinct sequence clade comprised of 19 S. mansoni and 40 S. mediterranea proteins
was identified and labeled Platyhelminth Rhodopsin Orphan Family 1 (PROF1). Members of
this novel and highly-diverged phylogenetic grouping are predicted to house a 7TM domain
with an extracellular N-terminus and seem to be exclusively derived from intronless genes.
Most PROF1 sequences were revealed with homology-based searches after a small number of
bait sequences survived the Rhodopsin HMM filtering stage. In fact, 31 of the 40 Schmidtea
PROF1-containing ORFs were identified via tBLASTn, and only one of these ORFs coincided
with an existing gene model. Similarly, 13 of 19 Schistosoma PROF1 were identified in this
manner and only four of these were represented in the predicted gene set.
These receptors display remnants of classical Rhodopsin motifs at corresponding positions (Ta-
ble 2.6), yet show no significant overall homology to any previously discovered GPCRs. It is
important to point out that the absolute requirement of GPCR-related BLAST homology as
part of the post-HMM filtering stage would have masked the identification of PROF1 recep-
tors. BLASTp searches of all PROF1 sequences against the NCBI nr database (E-value cutoff
= 0.1) returned no hits for the majority of sequences. The small pool of hits that did result,
exhibit both very poor homology and represent an incongruous range of receptors that include
peptide, lipid and odorant GPCRs. This further highlights the unique nature of these receptors.
Maximum parsimony analysis led to the subdivision of PROF1 into three primary phylogenetic
groupings with good bootstrap support (Figure 2.7). Group I is the largest among these with 27
and 13 members from S. mediterranea and S. mansoni, respectively. The lack of obvious one-
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to-one orthologs between species suggests expansion or contraction of these receptors occurred
after the splitting of planaria and trematodes in the flatworm lineage. Group II includes 6 S.
mansoni and 7 S. mediterranea sequences, while group III houses 6 S. mediterranea sequences.
It is likely that the closest related receptor to the ancestral gene for this family is contained
in group I or II. A multiple sequence alignment of TM domains I-IV (used for phylogenetic
analysis) is shown in Figure 2.8.
Of additional interest, short PROF1-like sequence fragments were identified in both genome
assemblies that could not be incorporated into full-length gene structures. These may constitute
pseudogenes, or be ascribed to errors in assembly. RT-PCR was used to confirm transcript
expression for a selection of putative full-length PROF1 receptors in Schmidtea: 8 from group
I, 2 from group II and 3 from group III (highlighted in Figure 2.7). Correct-sized amplicons
were visualized for all 13 targets. Similarly, we selected a representative from each Schistosoma
PROF1 grouping and confirmed transcription in the adult stage: SMP084270 from group I and
SMP041880 from group II. It is not currently possible to assign functions or putative ligands
for the PROF1 family. However, given that they constitute one of the largest Rhodopsin-
like subfamilies conserved between these monophyletic species, we suspect that they play an
important biological role in this phyla.
The Adhesion and Secretin Families
Adhesion and Secretin receptors show sequence similarity in their 7TM domains and are
commonly grouped as Class II GPCRs. The phylogenetic separation of these families un-
der the GRAFS paradigm is mirrored by noticeable structural differences in their N-terminal
ectodomains. Archetypal Adhesion GPCRs have a long N-terminus containing a diverse ar-
rangement of functional domains. In the vertebrate lineage, this family constitutes the second
largest grouping of GPCRs after Rhodopsin and is further partitioned into 8 clusters (I-VIII).
Secretin GPCRs usually display N-terminal hormone-binding domains (HBD) that confer re-
sponsivity to peptide hormones and are thought to descend from the group V Adhesion re-
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ceptors [173]. Additional Adhesion-like proteins have been identified in various organisms that
stake more dubious evolutionary positions. The insect Methuselah receptors are one such ex-
ample that have become the subject of great investigation, attributable to their role in life-span
regulation and stress resistance [174]. More recently, a cluster of Adhesion-like receptors (NvX)
was identified in the basal Cnidarian N. vectensis which share some homology with Methuselah
receptors [173,175].
We have identified a novel cluster of 12 Schmidtea GPCRs that show moderate (> 20% PID)
homology to NvX receptors. We denote this cluster Planarian Adhesion-like receptor family
1 (PARF1). Like NvX, PARF1 receptors contain a single Somatomedin B domain, except in
the case of SMDC005966C which is predicted to contain two. Interestingly, no PARF1 or-
thologs were identified in S. mansoni. A single Adhesion GPCR in S. mansoni (SMP099670)
was found to house a Somatomedin B domain, but it otherwise shares no significant homol-
ogy with PARF1. Two Adhesion-like Schmidtea GPCRs (SMD002396 and SMD002965) were
identified that most resemble vertebrate group V orphan GPR133. Two Schmidtea GPR157
homologues (SMD002980 and SMD009091) were also identified via Adhesion/Secretin HMM,
however, these receptors exhibit vague sequence similarity to more than one GPCR family [115].
Latrophilin-like receptors were found to be present in both flatworms. Schmidtea SMD011811
contains a GPS domain, and can be grouped with sequence fragments SMDC001354A and
SMDC001354B. Schistosoma SMP176830 contains a Somatomedin B domain, but shares no
significant sequence similarity with the identified latrophilin-like planarian receptors. Evidence
of the potential druggability of these particular receptors comes from the parasitic nematode
Haemonchus contortus, where a latrophilin-like receptor has been identified as a target of an
anthelmintic cyclodepsipeptide [176]. One other Adhesion-like parasite GPCR was identified
(SMP058380) that displays an N-terminal GPS domain, but with no clear planarian ortholog.
The Secretin flatworm complement is comparatively smaller. Two S. mansoni and one S.
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mediterranea Secretin GPCRs were identified. SMP125420 and its planarian ortholog SMD004009
show high sequence similarity to diuretic hormone receptors and contain an N-terminal hor-
mone receptor domain (HRM). These receptors likely play a role in homeostatic regulation.
Schistosome SMP170560 exhibits an HRM domain and parathyroid hormone receptor homol-
ogy. This receptor may in fact have a planarian ortholog, but despite the recognition of a
short, nearly identical Schmidtea sequence fragment, we were unable to identify the rest of the
hypothetical gene within the assembly.
The Glutamate Family
Glutamate GPCRs respond to a wide range of signals, including glutamate, γ-aminobutyric
acid (GABA), Ca2+ and odorants. The mammalian complement of metabotropic glutamate
receptors (mGluRs) consists of 8 proteins that fall into 3 groups. They universally pos-
sess a large extracellular domain that contains within it a ligand binding domain (LBD).
The Drosophila mGluR-like complement consists of two receptors, DmGluRA and DmXR.
DmGluRA shares the structural profile of mammalian mGluR2 and mGluR3. DmXR consti-
tutes one member of a larger insect-specific clade, and displays an atypically-diverged LBD
that responds to L-canavanine [177,178]. Outside of the metazoa, a group of 17 Dictyostelium
GABAB-like receptors (GrlA-GrlR) have been forwarded as potential evolutionary precursors
to mGluRs [179,180].
We identified 2 Schistosoma and 9 Schmidtea Glutamate-like sequences. Phylogenetic analysis
of these sequences was performed with respect to both mammalian and non-mammalian Gluta-
mate receptors (Figure 2.9). The S. mansoni Glutamate-like receptors both have corresponding
orthologs in the Schmidtea genome. GSMP052660 and its ortholog GSMD025402 group with
DmGluRA, and most of the remaining planarian sequences fall in the phylogenetic vicinity of
the major mGluR groupings. However, GSMP128940 and its ortholog GSMD001419, along
with GSMD004608, seem to be significantly diverged from both GABAB and mGluR recep-
tors. In the case of DmXR and Grl receptors, the examination of key LBD residues involved
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in glutamate binding led to the eventually validated conclusion that glutamate was not the
primary ligand. We perform similar analysis as depicted in Figure 2.10. Although the residues
of GSMD001419 involved in α-amino and α-carboxylic groups of glutamate are conserved, the
residues associated with the γ-carboxylic group are not. This runs parallel to the observations
made for DmXR. GSMP128940 displays an even more atypical LBD and conserves only a single
putative glutamate-interacting residue. We hypothesize that these particular receptors either
bind other amino acid-derived ligands or possess unusual pharmacological profiles.
The Frizzled Family
Wnt-mediated Frizzled signaling plays a significant regulatory role in a number of crucial devel-
opmental processes, including cell fate determination, cell motility, cell polarity, and synaptic
organization [181]. In planaria, the canonical Wnt/β-catenin pathway is implicated as a molec-
ular switch for anteroposterior polarity in regeneration [156,182]. We identified four S. mansoni
Frizzled sequences, along with the 10 S. mediterranea sequences previously identified. A single
Smoothened-like sequence was found for each species.
In humans, 10 Frizzled receptors are grouped into four clusters based on sequence identity:
Fzd1/Fzd2/Fzd7 (I), Fzd5/Fzd8 (II), Fzd4/Fzd9/Fzd10 (III), and Fzd3/Fzd6 (IV) [181]. Both
flatworm genomes house a single receptor (FSMP118970 and FSMD000018) that groups in clus-
ter IV, sharing ∼45% amino acid identity with Drosophila Fzd1 and ∼38% identity with human
Fzd6. Four planarian (FSMD023435, FSMD010098 and FSMD000054) and two schistosome
(FSMP139180 and FSMP155340) receptors appear to belong to cluster II. Other flatworm
Frizzled receptors show less clear relationships with their vertebrate counterparts.
Ligand-based support vector machine (SVM) Rhodopsin subclassification
Support vector machines (SVMs) represent a powerful supervised-learning method for data
classification. Given a combined set of positively and negatively labeled training instances, an
SVM produces a binary classifier that can then be used to label unknown samples. Each in-
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stance is associated with a fixed-length numerical feature vector, containing certain attributes
of the data to be classified. The SVM identifies a maximum-margin separating hyperplane
to distinguish between vectors representing instances of opposite sign. More often than not,
training instances are not linearly separable in the feature space, and feature vectors must
first be mapped to a higher dimensional space. Non-linear classification is then performed by
application of kernel functions which allow for the construction of a hyperplane in the trans-
formed feature space. Recently, this approach has seen extensive use in the area of biosequence
discrimination, and relevant to our goals, the particular problem of GPCR classification.
In the first study on the matter, SVM-based classifiers were shown to drastically outperform
their BLAST and HMM-based counterparts for level 1 and level 2 GPCR subclassification [132].
Subsequent studies further improved the predictive performance of SVMs with the introduction
of dipeptide composition feature vectors [133,134], achieving accuracies of 97.3% and 96.4% for
level 1 (Rhodopsin) and level 2 (amine) classification, respectively. Alternative feature vectors
have since been similarly validated [135, 136]. Although these computational approaches are
touted as among the most sensitive, to the best of our knowledge, they have seen no utilization
in the realm of genome-wide GPCR mining studies.
Perhaps one reason for this is that even in the case of publicly available SVM classifiers, training
and validation occurs exclusively with full-length sequence data. More suitable classifiers would
be tailored to the general deficiencies of sequence data resulting from in silico methods, where
inexact gene structures are an unavoidable phenomenon. In this respect, we developed a
classifier to complement our particular GPCR identification approach. This involved focusing
SVM training on transmembrane domains, as identification of these conserved blocks had been
a primary aim of both our receptor mining and manual curation protocols.
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Multi-class SVM
Multi-class SVMs refer to classification problems where the number of classes, k, is greater than
2. Such problems are typically solved using either the “one-versus-rest” (OvR) or “one-versus-
one” (OvO) method. In the OvR scenario, k binary classifiers are trained, such that each
classifier separates one class from all others. The “winner-takes-all” strategy is then commonly
used to label unknown samples, whereby the classifier with the highest output decision function
assigns the final class. In the OvO scenario, k(k−1)2 binary classifiers are constructed in a
pair-wise manner. A voting strategy is then typically employed in classification, whereby each
classifier accounts for one vote and the class with the maximum number of votes assigns the final
label. Although the OvO method has been shown to perform better on a number of fronts [137],
as far as the authors are aware, all previously described SVM-based GPCR classifiers available
for online use rely on the simpler OvR method. We constructed OvO GPCR classifiers for two
levels of Rhodopsin family sub-classification.
Building feature vectors for ligand-based receptor discrimination
The general fixed-length feature vector, ~F , contains frequency information for the 202(400)
possible dipeptides over a given stretch of sequence, L amino acids in length. Dipeptides are
counted in both possible frames and there are therefore L− 1 total amino acid pairs.
~F = 〈P1, P2, ..., P399, P400〉 (2.1)
Pi =
fi
L− 1 (2.2)
where fi represents the frequency of dipeptide i
To better associate an SVM-based classification approach with our gene-mining strategy, we
explored the idea of again focusing our efforts exclusively on the transmembrane domains.
Two options in the way of final feature vector construction were pursued: ~XT1 and ~XT7. ~XT1
represents the 400-element dipeptide frequency vector taken over the entire length of a TM-only
pseudosequence, while ~XT7 represents the 2800-element dipeptide frequency vector generated
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from the ordered concatenation of the dipeptide frequency vectors for the seven individual TM
domains. The standard dipeptide frequency vector calculated for full-length proteins, ~XFL, was
used for comparison. We will refer to the corresponding SVM classifiers as SVMT1, SVMT7,
and SVMFL.
~XT1 = {~F}TM1−TM7 (2.3)
~XT7 = {~F}TM1 ⊕ {~F}TM2 ⊕ {~F}TM3 ⊕ {~F}TM4 ⊕ {~F}TM5 ⊕ {~F}TM6 ⊕ {~F}TM7 (2.4)
~XFL = {~F}FL (2.5)
SVM training: cross-validation and grid search
Rhodopsin training sequences were divided into 17 subfamilies using the GPCRDB classi-
fication system. Programs were written to process this training data into feature vector
form (Appendix F). Training was performed with the radial basis function (RBF) kernel,
K(xi, xj) = e
−γ‖xi−xj‖2 , and a grid search was used to tune parameters γ and C with 5-
fold cross-validation. For each proposed feature vector construction, the best performing (C,γ)
pair was selected in domains C = 2−5, 2−4, . . . , 215 and γ = 2−15, 2−14, . . . , 215 and used to
train a final classifier (Table 2.7).
Our original expectation was that SVMT1 would display lower accuracy than SVMFL, given
that a smaller subset of sequence information would be used for training. We hoped that this
presumed disparity would be compensated by SVMT7 with the addition of position-specific
information. Instead, both SVMT1 and SVMT7 registered higher cross-validation accuracies
than SVMFL for Rhodopsin subfamily classification. ~XT7 was the best-performing classifier with
99.47% accuracy. These results led us to conclude that for the Rhodopsin family, the exclusion
of sequence information outside of the transmembrane bundle improves dipeptide-based SVM
classification. Encouragingly, this is in agreement with structure and ligand interaction data
for the Rhodopsin family [183]. The same procedure was carried out in constructing classifiers
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for amine GPCRs. SVMT1 was the best performing classifier with a cross-validation accuracy
of 96.44%.
SVM classification results
Rhodopsin sequences with seven TM domains as predicted by HMMTOP were classified by the
two-tiered SVM. TOPs were aligned and manually examined to correct for erroneously predicted
TM domains. Sequences were then subclassified with the Rhodopsin SVMT7 classifier, and those
discerned as amine-responsive were further sub-classified with the amine classifier SVMT1. A
total of 121 S. mediterranea and 58 S. mansoni sequences were classified via Rhodopsin SVM.
The majority of these receptors were identified as peptide-responsive (Table 2.7). This grouping
also contains all PROF1 receptors included in this classification stage, perhaps providing some
clues as to their ligands. A subset of 22 S. mediterranea and 21 S. mansoni sequences were
identified as amine-responsive, and classified via amine SVMT1. These classification outputs
are detailed in Table 2.9. These results can inform receptor deorphanization efforts, alongside
traditional homology-based approaches.
2.3 Conclusions
This is the first comprehensive genome-wide study of G protein-coupled receptors in the phylum
Platyhelminthes. Our transmembrane-focused receptor mining approach yielded a lower-bound
estimate of 116 S. mansoni and 333 S. mediterranea GPCRs. Phylogenetic analysis established
the presence of the primary metazoan GRAFS families, along with well-populated α and β
Rhodopsin subfamilies in both examined genomes. The identification of these receptors com-
plements previous and ongoing efforts to identify biogenic amine and neuropeptide-like ligands
in flatworms, and will help identify specific receptors that mediate important aspects of flat-
worm biology associated with the aminergic and peptidergic signaling systems.
The flatworm GPCR repertoire is also shown to house entirely novel receptor groupings with
large numerical representation, including a Platyhelminth-specific Rhodopsin subfamily (PROF1)
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and a planarian-specific Adhesion-like family (PARF1). These particular lineage-specific ex-
pansions, along with the many other highly-diverged receptors identified, may reveal functional
innovations specific to these organisms. Many of these receptors have enhanced appeal as se-
lective pharmacological targets. While their diverged structures are an attractive feature in
the parasite drug discovery paradigm, it presents a challenge in posing more exact hypotheses
related to receptor function.
To further aid the process of functionally pairing receptors and ligands, we provide a prelimi-
nary classification of full-length receptors using SVMs. This represents the first effort to apply
SVMs to the problem of GPCR classification in a whole-genome manner, a task made difficult
by the evolutionary distance of flatworms from other species with well-characterized GPCR
complements. SVM results may be used in conjunction with phylogenetic and homology-based
approaches to receptor classification. As the quality of the underlying gene models improves,
and as a greater number of full-length receptor transcripts are sequence characterized, these
SVMs can be applied to an expanding subset of identified GPCRs. Functional characteriza-
tion of flatworm GPCRs is also likely to improve SVM accuracy by providing better training
examples.
The notion that schistosome GPCRs represent lucrative anthelmintic drug targets is strength-
ened by data on the crucial biological role of related receptor signaling molecules in nearly-
related organisms [184,185], as well as that of predicted platyhelminth GPCR ligands [164,165,
169,171]. The receptors, ligands and downstream biochemical pathways associated with GPCR
signaling have been identified as potential targets for parasite life-cycle interruption [15, 186].
Enlistment of schistosome reverse genetics approaches alongside receptor sequence data can
lead to the validation of specific receptors as drug targets.
In this regard, RNAi in schistosomes [69,70] provides new opportunities for focused exploitation
of this dataset. A simple medium-throughput phenotypic classification system has recently
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been described for both schistosomula and adult schistosomes [14]. These endpoints could
readily be used in an RNAi-mediated GPCR loss-of-function screen. Assaying the temporal
expression profiles of parasite GPCRs can also be a worthwhile measure as a selection tool for
receptors expressed in intra-host stages. On this front, we further the case for planarians as a
convenient model organisms to interrogate the function of trematode receptors, and provide a
list of inter-species receptor pairings ranked by sequence identity.
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2.5 Methods
Predicted proteomes and training sequences
The most recent release of the S. mansoni genomic assembly is accompanied with a set of 13,197
predicted proteins [24]. The S. mediterranea predicted proteome consists of 31,955 predicted
proteins that were produced with MAKER, although this number may represent a significant
overestimate of the true protein count [26,27]. HMM and SVM training sequences were down-
loaded from GPCRDB [107] in FASTA file format. In total, 268 Glutamate, 5025 Rhodopsin,
175 Adhesion, 354 Frizzled and 185 Secretin sequences were procured for HMM training. 20,920
GPCRDB sequences were used for Rhodopsin SVM training, and 2,105 sequences were used for
amine SVM subclassification.
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Nomenclature
Putative receptors retain their original GeneDB or MAKER IDs in slightly modified form. In
cases where a gene model was created, receptors were given a label in similar form that includes
genomic contig or scaffold information. Letters are appended to the ends of these labels where
necessary to distinguish among multiple gene models associated with a single contig or scaffold.
All putative flatworm GPCR sequences are provided in association with their tentative IDs.
Transmembrane domain prediction
We applied two common algorithms, TMHMM 2.0 [129] and HMMTOP 2.1 [128], to identify
transmembrane domains in our GPCR training set. HMMTOP correctly predicted 7 TM
domains for 93.8% (4712/5025) of Rhodopsin family receptors, compared to 81.9% (4119/5025)
in the case of TMHMM. This disparity in sensitivity held for all GPCR families, and was the
basis for our decision to employ HMMTOP for most subsequent work. A robust Perl script
(Appendix F) was written to parse coordinate predictions output from HMMTOP, and to
generate sequence files containing only regions of interest from the original protein sequences
as required.
TM-focused Profile hidden Markov model (HMM) construction
Provided a multiple sequence alignment, HMMER-2.3.2 [126] builds a probabilistic model
(profile HMM) that can be used to query sequence databases to find (or align) homologous
sequences. To prepare each GPCR family training set, predicted TM domains flanked bi-
directionally by 5 amino acids were extracted and concatenated using coordinates produced
in the previous section. These sequences were aligned with Muscle 3.6 [187] and a profile
HMM was constructed for each family with hmmbuild. All models underwent calibration using
hmmcalibrate, with the default parameters.
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HMM-based GPCR identification
All predicted proteins in the S. mansoni and S. mediterranea genomes with a predicted number
of TM domains in the range of 3-15 were processed in a manner identical to the HMM training
set. These TOP-converted protein sets were searched against our family-specific profile HMMs
using hmmpfam. The resulting hits for each GPCR family were ranked according to e-value,
and a cut-off was selected at the point where subsequent hits showed significant homology to
other known proteins or GPCRs belonging to other families. This was accomplished with a
BLASTp search of all hits against the NBCI nr database. The BLAST results were parsed
with a script (Appendix F) and top results were examined for removal of false positives.
Manual curation of putative GPCR-encoding genes
A large number of GPCR sequences underwent manual inspection of gene structure, and the
original predictions were edited where possible. Common manual edits included the merging
or splitting of gene models, modification of intron-exon boundaries, and sequence extension
or truncation in either or both directions. All editing was performed with Artemis [188].
Curation was primarily guided by homology-based searches and identification of TM domains
and family-specific GPCR motifs in ORFs that occurred in the vicinity of a gene model. In
the case of S. mansoni, this labor-intensive process was aided by the extraction of GeneDB
annotations for scaffolds thought to contain one or more receptors. More specifically, a script
was written to compile pertinent scaffold information stored in EMBL formatted files, including
the orientation, the number of predicted transmembrane domains and the top BLAST hits for
all proteins identified by our profile HMMs. This data was parsed into a spreadsheet and proved
significant in helping identify instances where manual curation was appropriate. In the case
of S. mediterranea, annotated genomic regions were loaded into Artemis in GFF3 format and
edited in a similar manner.
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Phylogenetic analysis
Near full-length (TM > 5) receptors were first processed for removal of the N- and C-termini.
ClustalX 2.0 [189] was used to generate multiple sequence alignments of the GPCRs to be
examined, with default parameters. PFAAT [190] was used to edit the resulting alignment
with attention to key motifs and residues housed within transmembrane domains. Low-entropy
sequence blocks present in all sequences were retained. The Phylip 3.6 [191]package was used to
generate phylogenetic trees. Alignments were bootstrapped using seqboot. Maximum parsimony
trees were calculated with protpars with input order randomized. Neighbor-joining trees were
calculated with protdist and neighbor using the JTT (Jones-Taylor-Thornton) distance matrix
and with input order randomized. Consensus trees were built with consense, and visualized
and edited with FigTree.
PROF1 RT-PCR
Total RNA was extracted from flatworm (schistosome or planarian) tissue using the RNAque-
ous Kit (Ambion), and RNA was treated with Turbo DNAase (Ambion) per manufacturer’s
instructions. A two-step RT-PCR was performed, where reverse transcription was first carried
out with the Retroscript kit (Ambion). Primers were designed for two schistosome PROF1
sequences and 13 planarian PROF1 sequences using Primer 3.0 [192] (Appendix C). PCR
products were visualized by agarose gel electrophoresis to confirm transcript expression.
SVM
Programs were written to process training sequences into feature vector form for the training
of three SVM classifiers: SVMT1, SVMT2, and SVMFL (Appendix F). TM prediction was
performed on training sequences with HMMTOP, and fixed-length dipeptide frequency vectors
were calculated in correspondence with each model. SVMs were implemented with the the
LIBSVM [193] package. The RBF kernel was chosen and a grid-search was performed with
an available python script for selection of kernel parameters. C and γ were assayed in the
domains C = 2−5, 2−4, . . . , 215 and γ = 2−15, 2−14, . . . , 215 to identify the C,γ pair that
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maximizes 5-fold cross validation ACC. The classifiers were trained in accordance with the
GPCRDB ligand-based groupings, and applied to a subset of flatworm Rhodopsin receptors
with 7 predicted TM domains.
2.6 Figures
Figure 2.1 - Transmembrane domain-focused GPCR sequence mining strategy.
(A) Family-specific profile HMMs are built using TM-only pseudosequences (TOPs) extracted
from the GPCRDB [107] sequence repository. The predicted proteomes of both S. mansoni
and S. mediterranea are processed in a manner identical to that of the training sequences and
are searched against a set of family-specific profile HMMs. Results are ranked statistically
and sequences meeting a conservatively selected cutoff undergo an automated BLASTp cam-
paign against the NCBI “nr” database. The output is parsed, and transmembrane proteins
exhibiting significant homology to non-GPCR proteins are removed. Redundant sequences are
removed with the BLAT utility. The surviving sequence pool is then manually assessed and
curated, followed by tBLASTn of sequences against the whole genome assemblies. Adhesion
and Secretin GPCR sequences are distinguished from one another by inspection of their N-
terminal ectodomains. Putative full-length Rhodopsin GPCRs, defined by the presence of an
intact 7TM domain, are sub-classified via SVM. (B) Construction of TOPs is a two-step process
involving the prediction of TM boundary coordinates by HMMTOP, followed by the ordered
concatenation of TM domains flanked bi-directionally by 5 amino acids.
Figure 2.2 - HMM-based identification of S. mansoni and S. mediterranea GPCRs.
The transmembrane frequency distribution of the S. mansoni (left) and S. mediterranea (right)
predicted proteomes is shown as predicted by HMMTOP at various junctures of the bioinfor-
matics protocol for the Rhodopsin family. The top graphs overlay the HMM-derived sequence
pools (black, yellow outline) on top of the entire predicted proteomes (white, black outline) in
the assayed TM domain range (3-15). The middle graphs overlay the BLASTp filtered sequence
pools (black, yellow outline) on top of the HMM-derived pools (white, black outline). The bot-
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tom graphs display the final distributions upon filtering, and after the removal of redundant
sequences in the case of S. mediterranea.
Figure 2.3 - Manual curation and expansion of Schistosoma mansoni GRAFS GPCRs.
The transmembrane distributions for the filtered S. mansoni HMM pool is shown before (top)
and after (middle) manual editing of the underlying gene models, as predicted by HMMTOP.
The number of GPCRs with a predicted intact 7TM domain increases from 27 to 41, coupled
with a significant contraction of the distribution spread. The mean TM count shifts from 6.00 to
6.41, which equates to the identification and addition of roughly 42 missing TM domains during
the first round of curation. Homology-bases searches against the genome assembly increased
the putative 7TM receptor count to 59 (bottom). Receptors in the 8 and 9 TM bin can be
considered full-length for our purposes, as the erroneously-predicted additional TM domains
can be excised for phylogenetic analysis. Inclusion of these receptors brings the total putative
full-length (7TM) receptor tally to 68 (of 116 total sequences).
Figure 2.4/ 2.5 - GRAFS and Rhodopsin phylogenetic trees.
(A) Overall topological view of the combined S.mansoni and S. mediterranea GPCR comple-
ments. Maximum parsimony analysis (bootstrap value = 100) was carried out using putative
full-length non-Rhodopsin GPCRs and a subset of full-length Rhodopsin-like GPCRs. In addi-
tion to the phylogenetic clustering of sequences into the primary GRAFS families, this analysis
reveals the presence of two distinct phylum-specific groupings: PROF1 and PARF1. * Sequence
family is present in S. mediterranea. ** Sequence family is present in both S. mansoni and
S. mediterranea. (B) Neighbor-joining tree of flatworm Rhodopsin-like GPCRs. To maximize
the number of sequences included in this analysis, a sequence block housing TM domains I-IV
was extracted from the overall alignment. This allowed for inclusion of 312 Rhodopsin-like
sequences: 90 S. mansoni and 224 S. mediterranea receptors (bootstrap value = 200). The α
(amine and opsin), peptide, melatonin, and PROF1 groupings are highlighted. Branches ter-
minating in Schistosoma receptors are shown in green, and branches terminating in Schmidtea
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receptors are shown in blue. Original concensus tree with bootstrap values and sequence labels
is available.
Figure 2.6 - Aminergic receptors: S. mediterranea and S. mansoni.
Neighbor-joining tree (bootstrap value = 500) of putative biogenic amine-responsive GPCRs.
Included in this analysis are 21 (of 25) S. mansoni and 58 (of 65) S. mediterranea full-length
and near full-length aminergic receptors, alongside 14 known C. elegans biogenic amine recep-
tors. The latter grouping includes receptors that respond to tyramine, octopamine, dopamine,
serotonin, and acetylcholine [194]. Branch lengths are scaled to bootstrap support, branches ter-
minating in Schistosoma receptors are shown in green, and branches terminating in Schmidtea
receptors are shown in blue. Flatworm receptors are outlined (solid lines) and classified by lig-
and with respect to their nearest-related C. elegans homologs. Two diverged flatworm-specific
receptor groupings are outlined in dashed lines.
Figure 2.7 - Phylogenetic analysis of PROF1 GPCRs.
Maximum parsimony tree for all identified PROF1 receptors. An alignment block that included
TM domains I-IV was bootstrapped 1000 times for parsimony analysis. PROF1 can be sub-
divided into 3 families with good bootstrap support (> 50%; relevant values displayed): I, II
and III. Schistosome sequences are shown in green and Schmidtea sequences are shown in blue.
The tree is rooted with a Schistosoma opsin-like GPCR (AAF73286.1). Schmidtea PROF1
receptors with transcript expression confirmed by RT-PCR are marked with red asterisks.
Figure 2.8 - PROF1 multiple sequence alignment.
Multiple sequence alignment of all PROF1 receptors over a sequence range that includes TM
domains I-IV (used for phylogenetic analysis). Residues are colored according to an identity
threshold set at 80% within each group. The locations of individual TM domains were approx-
imated by alignment to Rhodopsin and are depicted above the MSA. Red asterisks are used
51
to mark residue locations where the among-group PROF1 identity level threshold (> 80%) is
met.
Figure 2.9 - Phylogenetic analysis of Glutamate GPCRs.
Maximum parsimony tree of Glutamate family GPCRs. TM domains I-VII were used for
phylogenetic analysis with the alignment bootstrapped 1000 times (bootstrap support val-
ues are provided). Schistosome sequences are shown in green and Schmidtea sequences are
shown in blue. GSMD007320 and GSMD015264 were excluded as they remain incomplete over
the sequence range used. GABAB receptors are highlighted, along with the primary verte-
brate mGluR groupings and the more recently discovered insect Group X receptors. A human
Calcium-sensing receptor (AAA86503.1) was used as an outgroup. Putative flatworm GPCRs
that are diverged from both the GABAB and glutamate-responsive receptors are outlined in
red. The ligand-binding domains of these receptors are further analyzed in Figure 9.
Figure 2.10 - Schematic of glutamate in association with LBD residues.
Conserved mGluR LBD residues involved in glutamate binding are shown (underlined) in com-
parison with the corresponding residues for flatworm Glutamate-like receptors GSMP128940
and GSMD004608. Numbers represent residue location with respect to the mouse mGluR3
sequence. Disagreement at a given position is highlighted in red. GSMP128940 displays overall
divergence with the canonical glutamate binding pocket, while GSMD004608 retains only key
residues that interact with the glutamate α-carboxylic and α-amino groups.
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2.7 Tables
Table 2.1 - Tabulated GPCR sequence count at various stages of processing.
Sequence counts are provided for each GPCR family at different stages in the receptor mining
protocol. The S. mansoni count is shown after application of the TM-focused HMM and
filtering of the predicted proteome (HMM), extensive manual curation (MC), homology-based
searches against the nucleotide assembly (tBLASTn) and a final round of manual curation
(Final). This progression is similarly displayed for S. mediterranea, with additional stages for
the shedding of redundant sequences using BLAT (R).
Table 2.2 - GRAFS-based comparison of GPCR repertoires.
The GPCR repertoires of S. mansoni and S. mediterranea are shown from a GRAFS-based
perspective, alongside those of other organisms with characterized GPCR complements. For
Rhodopsin sub-classification, BLAST searches were used to help tentatively assign putative
ligands to receptors omitted from phylogenetic analysis.
Tables 2.3, 2.4, 2.5 - Identification of Planarian sequelogs of parasite Rhodopsin
receptors.
The nearest S. mediterranea sequelog of each S. mansoni Rhodopsin receptor is shown, along
with the length of the BLASTp overlap region and the corresponding E-value. Receptor pairs
are ranked by percent identity (PID). Parasite receptors closest to top of the table are likely
candidates for indirect characterization via investigation of their nearest-related planarian coun-
terpart.
Table 2.6 - Comparison of PROF1 motifs and classical Rhodopsin motifs.
PROF1 motifs are compared to ubiquitous Rhodopsin family motifs. Motifs are displayed as
regular expressions. The two most frequently occurring amino acids are shown for each position
in order of frequency, except in cases where a particular residue is absolutely conserved or when
there is no clear second in frequency rank. Red text is used to highlight positional agreement
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between PROF1 motifs and the corresponding Rhodopsin motifs. More specifically, instances
where the most frequently occurring residue is equivalent.
Table 2.7 - Rhodopsin SVM training parameters and cross-validation accuracy.
RBF grid-search parameters used to train SVM models, along with the corresponding 5-fold
cross-validation accuracy (ACC) for the training set. The best performing model for level
2 (subfamily) classification is SVMT7, while the best performing model for level 3 (amine)
classification is SVMT1. Both classifiers exclusively employ transmembrane sequence data, and
outperform the classifiers trained with full-length sequence data.
Table 2.7 - Rhodopsin SVM classifier results.
Ligand-based classification of flatworm Rhodopsin GPCRs with Rhodopsin SVMT7. PROF1
receptors are labeled with ‘*’. A total of 178 receptors were classified, with the vast majority
placed in the peptide and amine groupings. Interestingly, all 45 PROF1 receptors were classified
as peptide-responsive.
Table 2.9 - Amine SVM classifier results.
Ligand-based classification of flatworm amine-responsive GPCRs with amine SVMT1. A total
of 43 receptors were identified as aminergic via Rhodopsin SVM classification. In cases of
erroneous TM boundary prediction, the SVMFL classifier was used. The classifier results
display correct predictions for the three schistosome receptors thus far deorphanized in this
subfamily, including two histamine-responsive GPCRs and one dopamine-responsive GPCR
(labeled with ‘*’).
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S. mansoni Query Length S. mediterranea Hit Length Overlap E-value PID
SMP145540 492 mk4.017782.00.01 278 206 6.00E-90 69%
SMP148210 279 mk4.007388.02.01 339 196 2.00E-65 62%
SMP169680 178 mk4.000219.07.01 424 82 3.00E-25 62%
SMP118040 354 mk4.000375.06.01 371 314 1.00E-103 60%
SMP126730 463 mk4.007388.02.01 339 192 7.00E-62 59%
SMP152540 231 mk4.009070.00.01 704 131 5.00E-43 59%
SMP160020 320 mk4.013690.00.01 458 157 3.00E-43 52%
SMP149770 318 mk4.013819.05.01 308 141 5.00E-39 52%
SMP134820 360 mk4.011160.01.01 484 197 2.00E-51 48%
SMP132410 383 mk4.000375.06.01 371 314 4.00E-78 47%
SMP133550 503 mk4.010211.00.01 370 236 2.00E-53 47%
SMP140620 170 mk4.018209.00.01 365 171 3.00E-39 47%
SMP123350 535 mk4.000301.14.01 386 87 7.00E-24 47%
SMP127720 518 mk4.012183.00.01 509 167 1.00E-39 44%
SMP120620 587 mk4.002108.03.01 224 112 3.00E-26 44%
SMP001070.1 197 SMDC2955.1 334 126 4.00E-26 44%
SMP000900 412 mk4.001208.04.01 152 141 3.00E-25 43%
SMP150180 483 mk4.012659.00.01 387 417 9.00E-80 42%
SMP043340 551 mk4.005650.02.01 421 189 2.00E-35 41%
SMP043290 497 mk4.005650.02.01 421 168 2.00E-34 41%
SMPSC31 241 mk4.002460.05.01 306 160 1.00E-27 41%
SMP172810 450 mk4.000557.00.01 337 75 2.00E-12 41%
SMP134350 421 mk4.002485.01.01 254 213 9.00E-49 40%
SMP011940 396 mk4.002418.01.01 447 321 2.00E-72 39%
SMP194740 265 mk4.012712.00.01 279 143 3.00E-18 39%
SMP149580 377 mk4.010306.00.01 320 342 1.00E-55 38%
SMP145240 581 mk4.015843.00.01 270 246 2.00E-40 38%
SMP058080 319 mk4.000152.09.01 261 218 6.00E-39 38%
SMPSC12B 244 SMDC1889.2 392 198 6.00E-38 38%
SMP161500 302 mk4.025533.00.01 287 216 1.00E-37 38%
SMP043320 584 mk4.000354.16.01 413 173 5.00E-36 38%
SMP043260 560 mk4.000354.16.01 413 183 1.00E-34 38%
SMPSC103 526 mk4.000354.16.01 413 171 3.00E-33 38%
SMP164730 542 mk4.025533.00.01 287 209 1.00E-31 38%
SMP157050 387 mk4.014274.00.01 409 167 3.00E-25 38%
Table 2.3 Planarian homologs of parasite GPCRs.
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S. mansoni Query Length S. mediterranea Hit Length Overlap E-value PID
SMPSC10893 251 SMDC2411.1 385 128 6.00E-19 38%
SMPSC433 371 SMDC1889.2 392 367 4.00E-66 37%
SMP041880 342 SMDC2411.1 385 366 2.00E-62 37%
SMP134100 293 mk4.005562.01.01 324 295 1.00E-51 37%
SMP043300 522 mk4.000354.16.01 413 172 5.00E-34 37%
SMP023710 465 SMDC2411.1 385 134 1.00E-22 37%
SMP140250 196 mk4.005799.01.01 323 140 1.00E-21 37%
SMP104210 329 mk4.011006.00.01 348 127 4.00E-20 37%
SMP146450 367 mk4.012231.01.01 343 127 1.00E-16 37%
SMP170020 407 mk4.033855.01.01 243 187 8.00E-30 36%
SMP137050 454 mk4.002108.03.01 224 217 5.00E-35 35%
SMP157640 482 mk4.022218.00.01 344 127 1.00E-12 35%
SMP129810 497 mk4.006543.02.01 440 404 2.00E-61 34%
SMP091950 366 SMDC1889.2 392 363 6.00E-57 34%
SMP172170 243 mk4.000152.09.01 261 220 3.00E-28 34%
SMP043270 490 mk4.000354.16.01 413 175 3.00E-29 33%
SMP117340 192 SMDC2411.1 385 133 2.00E-21 33%
SMP164140 272 mk4.004167.00.01 260 145 5.00E-18 33%
SMP135660 461 mk4.001407.02.01 330 75 0.016 33%
SMP167870 319 SMDC1889.2 392 291 4.00E-42 32%
SMPSC1003 373 SMDC1889.2 392 362 1.00E-40 32%
SMP173010 354 mk4.002460.05.01 306 259 9.00E-37 32%
SMP056080 532 mk4.012712.00.01 279 283 3.00E-35 32%
SMPSC12A 305 SMDC1889.2 392 234 3.00E-35 32%
SMPSC74 411 mk4.001407.02.01 330 277 6.00E-29 32%
SMP141880 492 mk4.011130.02.01 209 138 6.00E-16 32%
SMP083880 247 mk4.008619.00.01 542 83 1.00E-07 32%
SMP132730 278 mk4.024092.00.01 427 67 4.00E-06 32%
SMP180030 369 mk4.007964.02.01 210 190 2.00E-20 31%
SMP162870 195 mk4.021981.00.01 316 141 8.00E-20 31%
SMP084280 355 SMDC1889.2 392 307 1.00E-40 30%
SMPSC63 358 SMDC6472.1 368 340 4.00E-40 30%
SMP072450 460 mk4.013492.00.01 417 379 1.00E-36 30%
SMPSC331A 354 SMDC1889.2 392 333 8.00E-35 30%
SMP149170 441 mk4.031060.00.01 384 345 2.00E-30 30%
Table 2.4 Planarian homologs of parasite GPCRs- continued.
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S. mansoni Query Length S. mediterranea Hit Length Overlap E-value PID
SMP178420 328 mk4.004400.01.01 317 149 1.00E-15 30%
SMP134460 521 mk4.005650.02.01 421 444 3.00E-42 29%
SMP084290 364 SMDC6472.1 368 340 8.00E-37 29%
SMP007070 580 mk4.000219.07.01 424 318 1.00E-30 29%
SMP159860 468 mk4.004728.01.01 352 126 2.00E-13 29%
SMP132220 135 mk4.008535.00.01 402 78 8.00E-07 29%
SMP153210 392 mk4.014320.00.01 350 98 6.00E-06 29%
SMP134960 367 SMDC2411.1 385 345 5.00E-36 28%
SMP084270 369 SMDC1889.2 392 302 1.00E-33 28%
SMP059400 291 mk4.005650.02.01 421 338 1.00E-26 28%
SMP127310 545 mk4.013690.00.01 458 466 1.00E-41 27%
SMP145520 379 mk4.000354.16.01 413 319 2.00E-36 27%
SMP083940 352 SMDC8510.2 380 350 8.00E-31 27%
SMPSC15 409 mk4.000596.05.01 315 310 5.00E-28 27%
SMP008850 515 mk4.011509.03.01 461 381 3.00E-26 27%
SMPSC34 365 mk4.002618.00.01 384 314 2.00E-21 27%
SMP180350 190 mk4.010158.01.01 325 152 2.00E-19 27%
SMP027940 324 mk4.004400.01.01 317 271 2.00E-18 27%
SMP180140 354 mk4.001491.09.01 305 190 7.00E-12 27%
SMP170610 388 mk4.014274.00.01 409 117 4.00E-07 27%
SMP153200 367 mk4.000600.00.01 372 110 0.003 27%
SMPSC331B 353 SMDC1889.2 392 334 2.00E-28 26%
SMP128710 551 mk4.031060.00.01 384 258 7.00E-15 26%
SMP126890 324 mk4.002418.01.01 447 93 8.00E-08 26%
SMP137300 328 mk4.006327.00.01 315 292 5.00E-18 25%
SMP137310 327 mk4.004400.01.01 317 278 6.00E-18 24%
SMP137320 324 mk4.004400.01.01 317 290 2.00E-17 24%
SMP041700 367 mk4.021981.00.01 316 228 7.00E-16 24%
SMP137980 292 mk4.000600.00.01 372 298 2.00E-11 23%
SMP056060 487 mk4.012712.00.01 279 227 4.00E-10 23%
SMPSC261 229 mk4.014320.00.01 350 176 0.002 23%
SMPSC58 323 mk4.006327.00.01 315 283 7.00E-21 22%
SMP128170 581 mk4.000038.11.01 391 321 2.00E-17 21%
SMP080820 209 mk4.002569.02.01 367 133 5.00E-05 21%
Table 2.5 Planarian homologs of parasite GPCRs- continued.
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SVM model Scoring scheme γ C 5-fold ACC
SVMT1 OvO 16.0 32.0 99.01%
Level 2: Rhodopsin SVMT7 OvO 2
−8 2048.0 99.47%
SVMFL OvO 256.0 32.0 98.65%
SVMT1 OvO 256.0 32.0 96.44%
Level 3: Amine SVMT7 OvO 32.0 2
4.5 95.0%
SVMFL OvO 256.0 32.0 94.77%
Table 2.7 Rhodopsin SVM training parameters and cross-validation accuracy.
71
S
.
m
a
n
.
S
.
m
ed
.
A
m
in
e
S
M
P
1
2
6
7
3
0
S
M
P
0
4
3
2
9
0
S
M
P
1
2
0
6
2
0
m
k
4
.0
1
1
3
7
1
.0
0
.0
1
m
k
4
.0
0
5
9
3
9
.0
1
.0
1
m
k
4
.0
0
9
5
2
8
.0
0
.0
1
S
M
P
1
2
7
3
1
0
S
M
P
0
4
3
3
0
0
S
M
P
1
8
0
1
4
0
m
k
4
.0
0
0
6
5
6
.1
0
.0
1
m
k
4
.0
0
1
5
8
5
.0
0
.0
1
m
k
4
.0
0
9
0
7
0
.0
0
.0
1
S
M
P
1
3
4
4
6
0
S
M
P
0
4
3
3
2
0
S
M
P
1
6
0
0
2
0
m
k
4
.0
0
3
2
0
2
.0
1
.0
1
m
k
4
.0
0
5
5
6
2
.0
1
.0
1
m
k
4
.0
0
5
7
6
6
.0
0
.0
1
S
M
P
1
3
4
8
2
0
S
M
P
0
4
3
3
4
0
S
M
P
S
C
1
0
3
m
k
4
.0
0
0
7
4
2
.0
9
.0
1
m
k
4
.0
0
0
8
8
3
.0
5
.0
1
m
k
4
.0
0
7
3
8
8
.0
2
.0
1
S
M
P
0
2
7
9
4
0
S
M
P
1
4
5
5
2
0
S
M
P
1
5
9
8
6
0
m
k
4
.0
0
3
0
0
2
.0
2
.0
1
m
k
4
.0
0
2
6
3
5
.0
0
.0
1
m
k
4
.0
2
9
3
2
5
.0
0
.0
1
S
M
P
1
3
7
3
0
0
S
M
P
1
4
5
5
4
0
m
k
4
.0
0
1
6
7
8
.0
3
.0
1
m
k
4
.0
0
7
5
3
8
.0
1
.0
1
m
k
4
.0
1
2
6
5
9
.0
0
.0
1
S
M
P
0
4
3
2
6
0
S
M
P
1
4
8
2
1
0
m
k
4
.0
1
1
1
6
0
.0
1
.0
1
m
k
4
.0
0
0
6
4
6
.0
0
.0
1
S
M
P
0
4
3
2
7
0
S
M
P
1
5
0
1
8
0
m
k
4
.0
0
1
5
6
9
.0
4
.0
1
m
k
4
.0
0
5
6
5
0
.0
2
.0
1
P
e
p
ti
d
e
S
M
P
1
3
4
9
6
0
*
S
M
P
1
8
0
1
4
0
m
k
4
.0
0
8
5
3
5
.0
0
.0
1
m
k
4
.0
0
9
5
2
6
.0
0
.0
1
m
k
4
.0
0
0
6
9
9
.1
1
.0
1
m
k
4
.0
0
1
9
7
4
.0
3
.0
1
S
M
D
C
2
1
1
1
6
.2
*
S
M
P
S
C
3
4
S
M
P
1
6
4
7
3
0
m
k
4
.0
0
2
4
1
8
.0
1
.0
1
m
k
4
.0
2
2
2
1
8
.0
0
.0
1
m
k
4
.0
0
0
5
9
6
.0
5
.0
1
m
k
4
.0
2
7
0
0
5
.0
0
.0
1
S
M
D
C
1
4
4
9
7
.4
*
S
M
P
1
3
7
3
1
0
S
M
P
0
5
6
0
8
0
m
k
4
.0
1
4
1
2
7
.0
0
.0
1
m
k
4
.0
0
8
5
5
5
.0
0
.0
1
m
k
4
.0
0
2
4
5
7
.0
0
.0
1
m
k
4
.0
0
1
4
1
9
.0
4
.0
1
S
M
D
C
6
8
5
8
.4
*
S
M
P
1
5
3
2
1
0
S
M
P
0
2
7
9
4
0
m
k
4
.0
2
1
5
7
3
.0
0
.0
1
m
k
4
.0
0
0
1
6
0
.1
5
.0
1
m
k
4
.0
0
0
6
0
0
.0
0
.0
1
m
k
4
.0
1
0
1
6
2
.0
0
.0
1
S
M
D
C
5
0
4
.1
*
S
M
P
S
C
5
8
S
M
P
1
3
7
0
5
0
m
k
4
.0
0
0
3
7
5
.0
6
.0
1
m
k
4
.0
0
0
7
8
7
.0
5
.0
1
m
k
4
.0
2
2
2
2
7
.0
1
.0
1
m
k
4
.0
0
5
9
3
9
.0
1
.0
1
S
M
D
C
1
8
0
0
0
.2
*
S
M
P
S
C
1
5
S
M
P
1
3
7
3
0
0
m
k
4
.0
0
2
6
1
8
.0
0
.0
1
m
k
4
.0
0
5
2
6
8
.0
2
.0
1
m
k
4
.0
0
4
4
0
0
.0
1
.0
1
m
k
4
.0
0
1
5
8
5
.0
0
.0
1
S
M
D
C
1
2
7
8
1
.1
*
S
M
P
1
3
7
3
2
0
S
M
P
0
0
7
0
7
0
m
k
4
.0
0
2
5
6
9
.0
2
.0
1
m
k
4
.0
0
6
0
9
7
.0
3
.0
1
m
k
4
.0
0
1
4
9
1
.0
9
.0
1
m
k
4
.0
0
7
3
8
8
.0
2
.0
1
S
M
D
C
1
5
1
6
8
.2
*
S
M
P
S
C
3
3
1
A
*
S
M
P
0
8
4
2
8
0
*
m
k
4
.0
0
8
7
7
4
.0
0
.0
1
m
k
4
.0
2
4
0
9
2
.0
0
.0
1
m
k
4
.0
1
4
2
4
5
.0
0
.0
1
S
M
D
C
9
4
3
.5
*
S
M
D
C
4
2
3
.2
*
S
M
P
S
C
3
3
1
B
*
S
M
P
0
9
1
9
5
0
*
m
k
4
.0
0
2
8
0
7
.0
3
.0
1
m
k
4
.0
0
6
2
4
8
.0
2
.0
1
m
k
4
.0
0
0
1
3
1
.0
0
.0
1
S
M
D
C
1
7
5
.4
*
S
M
D
C
1
0
2
6
.2
*
S
M
P
S
C
4
3
3
*
S
M
P
1
6
7
8
7
0
*
m
k
4
.0
0
4
7
1
1
.0
2
.0
1
m
k
4
.0
0
2
1
5
0
.0
0
.0
1
m
k
4
.0
1
0
8
3
4
.0
0
.0
1
S
M
D
C
8
5
1
0
.2
*
S
M
D
C
6
4
7
2
.1
*
S
M
P
S
C
1
0
0
3
*
S
M
P
1
4
5
2
4
0
m
k
4
.0
0
1
2
9
1
.0
1
.0
1
m
k
4
.0
0
7
7
7
6
.0
0
.0
1
m
k
4
.0
0
0
0
2
0
.0
8
.0
1
S
M
D
C
1
2
5
5
4
.3
*
S
M
D
C
1
9
1
7
.2
*
S
M
P
S
C
6
3
*
S
M
P
0
7
2
4
5
0
m
k
4
.0
0
5
5
9
9
.0
3
.0
1
m
k
4
.0
0
0
3
4
1
.0
5
.0
1
m
k
4
.0
4
4
2
1
5
.0
0
.0
1
S
M
D
C
2
7
5
2
1
.1
*
S
M
D
C
5
5
9
8
.1
A
*
S
M
P
1
7
0
0
2
0
S
M
P
1
5
7
0
5
0
m
k
4
.0
0
1
2
3
5
.0
1
.0
1
m
k
4
.0
2
8
0
1
4
.0
0
.0
1
m
k
4
.0
1
1
9
8
8
.0
0
.0
1
S
M
D
C
1
4
3
8
0
.2
*
S
M
D
C
5
5
9
8
.1
B
*
S
M
P
0
1
1
9
4
0
S
M
P
1
5
3
2
0
0
m
k
4
.0
1
0
2
1
1
.0
0
.0
1
m
k
4
.0
1
0
3
0
6
.0
0
.0
1
m
k
4
.0
2
2
6
0
7
.0
0
.0
1
S
M
D
C
8
5
1
0
.3
A
*
S
M
D
C
1
7
4
9
.3
A
*
S
M
P
1
4
1
8
8
0
S
M
P
0
8
4
2
7
0
*
m
k
4
.0
0
1
2
3
5
.0
4
.0
1
m
k
4
.0
0
2
5
1
4
.0
1
.0
1
m
k
4
.0
0
0
5
5
7
.0
0
.0
1
S
M
D
C
8
5
1
0
.3
B
*
S
M
D
C
1
7
4
9
.3
B
*
S
M
P
1
4
9
5
8
0
S
M
P
0
8
4
2
9
0
*
m
k
4
.0
1
8
2
0
9
.0
0
.0
1
m
k
4
.0
1
3
4
9
2
.0
0
.0
1
m
k
4
.0
0
9
2
4
8
.0
3
.0
1
S
M
D
C
1
5
3
8
5
.3
*
S
M
D
C
2
7
9
1
1
.2
*
S
M
P
1
7
3
0
1
0
S
M
P
0
8
3
9
4
0
*
m
k
4
.0
0
3
6
3
4
.0
0
.0
1
m
k
4
.0
3
0
4
7
6
.0
0
.0
1
m
k
4
.0
0
0
0
6
5
.0
2
.0
1
S
M
D
C
1
5
2
7
3
.1
*
S
M
D
C
9
0
7
.1
A
*
S
M
P
0
0
8
8
5
0
m
k
4
.0
0
5
8
0
9
.0
0
.0
1
m
k
4
.0
0
0
6
1
7
.0
1
.0
1
m
k
4
.0
0
1
2
8
3
.0
1
.0
1
S
M
D
C
4
3
5
0
.2
*
S
M
D
C
9
0
7
.1
B
*
S
M
P
1
2
3
3
5
0
m
k
4
.0
1
6
3
0
4
.0
0
.0
1
m
k
4
.0
1
1
5
0
9
.0
3
.0
1
m
k
4
.0
2
0
7
9
7
.0
1
.0
1
S
M
D
C
1
9
9
6
9
.1
*
S
M
D
C
1
8
2
5
.1
*
S
M
P
0
4
1
8
8
0
*
m
k
4
.0
1
8
6
8
2
.0
0
.0
1
m
k
4
.0
1
2
7
9
0
.0
1
.0
1
m
k
4
.0
0
0
2
1
9
.0
7
.0
1
S
M
D
C
1
4
7
3
6
.1
*
T
a
b
le
2
.8
R
h
od
o
p
si
n
S
V
M
cl
a
ss
ifi
er
re
su
lt
s.
72
S. mansoni S. mediterranea
SMP126730 4 mk4.011371.00.01 1
SMP127310 3* mk4.000656.10.01 2
SMP134460 4 mk4.003202.01.01 3
SMP134820 5 mk4.000742.09.01 3
SMP027940 5 mk4.003002.02.01 1
SMP137300 5 mk4.001678.03.01 6
SMP043260 4* mk4.011160.01.01 6
SMP043270 3 mk4.001569.04.01 2
SMP043290 5 mk4.005939.01.01 5
SMP043300 6 mk4.001585.00.01 5
SMP043320 5 mk4.005562.01.01 1
SMP043340 4* mk4.000883.05.01 1
SMP145520 5 mk4.002635.00.01 2
SMP145540 3 mk4.007538.01.01 2
SMP148210 5 mk4.000646.00.01 2
SMP150180 3 mk4.005650.02.01 1
SMP120620 6 mk4.009528.00.01 2
SMP180140 5 mk4.009070.00.01 1
SMP160020 5 mk4.005766.00.01 1
SMPSC103 2 mk4.007388.02.01 5
SMP159860 3 mk4.029325.00.01 6
mk4.012659.00.01 1
1: Muscarinic acetylcholine
2: Adrenoceptors
3: Dopamine
4: Histamine
5: Serotonin
6: Octopamine
7: Trace amine
Table 2.9 Amine SVM classifier results.
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3 Novel RNAi-mediated Approach to Probing Platyhelminth G
Protein-Coupled Receptors
A paper to be submitted.
Mostafa Zamanian 1,2,∗, Prince N Agbedanu 1, Michael J Kimber 1,2, Tim A Day 1,2,∗
Abstract
G protein-coupled receptors (GPCRs) represents the largest known superfamily of membrane
proteins extending throughout the Metazoa. There exists ample motivation to elucidate the
functional properties of GPCRs in the phylum Platyhelminthes, given the heavy health bur-
den exacted by pathogenic flatworms and the role of free-living flatworms as model organisms
for the study of developmental biology and their parasite counterparts. Efforts on this front
have been hampered by the unreliable nature of heterologous receptor expression platforms.
We validate and describe a loss-of-function approach for ascertaining the ligand and G protein
coupling properties of GPCRs in their native cell membrane environment. RNA interference
(RNAi) was used in conjunction with a GPCR biochemical endpoint assay to monitor cAMP
modulation in response to the translational suppression of individual receptors. This was used
to confirm GYIRFamide as the cognate ligand for Dugesia tigrina GtNPR-1, while revealing
its endogenous coupling to Gαi/o. The method was then applied to deorphanize a Schmidtea
mediterranea 5-HT receptor, Smed-SER-7. A bioinformatics protocol guided the selection of
receptor candidates mediating 5-HT-evoked responses. While these results establish the poten-
1Department of Biomedical Sciences, Iowa State University, Ames, IA USA
2Interdepartmental Neuroscience Program, Iowa State University, Ames, IA USA
∗Corresponding Authors. Emails: mostafaz@iastate.edu, day@iastate.edu
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tial of this approach, future work can help optimize and adapt this receptor deorphanization
strategy to a higher-throughput platform.
3.1 Introduction
G protein-coupled receptors (GPCRs) have been the subject of intense research scrutiny due
to their central role in eukaryotic signal transduction and their exploitability as drug tar-
gets [79, 80, 149]. The phylum Platyhelminthes houses prominent human pathogens as well
as tractable model organisms. Flatworm GPCRs represent lucrative anthelmintic targets, as
evidenced by the biological activities of their putative ligands [164, 169] and the crucial bio-
logical functions of these receptors in nearly-related organisms [184, 185]. Signaling pathways
associated with the GPCR superfamily have been specifically identified as potential targets for
life-cycle interruption of flatworm parasites [15, 186]. The identification and pharmacological
characterization of GPCRs is likely to generate lucrative drug discovery leads, while enhanc-
ing our basic understanding of receptor biology in this important phylum. This process has
been slowed by an exclusive reliance on traditional heterologous receptor expression approaches.
Once identified, GPCRs undergo deorphanization, the process of pairing orphan receptors with
their cognate ligands. The predominant approaches all require the transient or stable het-
erologous expression of GPCRs in a surrogate cell system and in most cases, this expression
occurs in cells derived from other species and phyla [148, 195, 196]. The complex regulatory
processes that guide the correct folding and export of receptors to the cell membrane [89–92]
are not necessarily well-conserved across cell lineages. Further, the structural and functional
integrity of receptors can depend on the local membrane lipid environment, the composition of
which can differ between native and heterologous cells [197,198]. The exact post-translational
requirements for proper receptor expression and function vary greatly among receptors, making
the task of identifying a suitable heterologous system a receptor-specific process of trial-and-
error [148].
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Recalcitrance of individual flatworm GPCRs to heterologous expression platforms has intro-
duced a significant bottleneck in implementing functional assays to identify receptor agonists.
Similar issues have impeded the structural elucidation of mammalian receptors [147]. Only a
handful of flatworm GPCRs have thus far been deorphanized, with receptors expressed in such
divergent cellular environments as CHO [138], HEK293 [139,140], COS7 [139], yeast [140,141],
and Xenopus oocyte cells [142]. We describe a relatively simple loss-of-function deorphaniza-
tion approach that could be applied in a native cell or membrane environment. This alternative
strategy could help catalyze a first-pass mapping of receptors and ligands in this phylum.
Inversing the Paradigm: RNAi as a Deorphanization Tool
We describe and validate an RNA interference (RNAi)-based method that allows receptors to
undergo deorphanization without the need for full-length cloning or transport to a heterologous
expression system. In principle, a collection of putative GPCR ligands are screened against
membrane preparations to evaluate their effects on second-messengers downstream of GPCR
activation. RNAi is then used to assay whether observed responses can be altered or abolished
by the knockdown of individual receptors from the membrane preparations. A successful “hit”
confirms expression of a given receptor, functionally pairs the receptor with a given ligand, and
couples the receptor with a specific G protein signaling pathway.
Bioinformatics approaches can be used to help identify receptors as putative targets for a partic-
ular ligand, or conversely, to narrow the list of potential ligands for a given receptor. The recent
availability of platyhelminth genomic data [24, 25, 27] has led to the accumulation of a wealth
of receptor and ligand data. A comprehensive in silico protocol revealed over 116 Schistosoma
mansoni and 333 Schmidtea mediterranea GPCRs, which were classified using phylogenetic,
homology-based, and machine-learning approaches [199]. Bioinformatics and proteomics-based
studies have also led to the expansion of the known set of putative GPCR ligands [169,171,172].
The primary biochemical endpoints of GPCR activation are typically assayed by recording
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agonist-evoked changes in cAMP (Gαs and Gαi/o) or Ca
2+ (Gαq) levels. A variety of es-
tablished labeling and detection schemes (e.g. fluorescent, luminescent, and radioisotope) are
available for these second messengers [200]. In this study, we focus our efforts on the Gαs
and Gαi/o pathways and employ a radioimmunoassay (RIA) for cAMP detection. Monitoring
adenylyl cyclase modulation of cAMP allows us to simultaneously examine two of the three
major GPCR activation endpoints.
While this loss-of-function approach limits pharmacological analysis, it is adaptable to higher-
throughput platforms and can serve as an efficient first-pass ligand-receptor mapping tool. It
should be noted that ligands and receptors can display pharmacological promiscuity. Ligands
can act through more than one receptor and receptors can respond to more than one ligand, with
a range of affinities. Further, receptors responsive to a given ligand do not necessarily share
the same G protein coupling profile and are likely to be expressed in different abundances.
However, this approach only concerns itself with the contribution of individual receptors to
differences between control and RNAi response profiles. The scale and directionality of the
differences between these profiles provide information relevant to ligand responsivity and G
protein coupling, respectively. The basic logic of this deorphanization strategy is outlined in
Figure 3.1.
3.2 Results and Discussion
cAMP Assay Optimization and Ligand Screen
A cell membrane preparation protocol was adapted [201] and optimized for planaria, and used
to generate samples for treatment with various GPCR ligands. The downstream effects of lig-
and incubation on cAMP levels were monitored using a cAMP RIA. A ligand screen was first
carried out on Dugesia tigrina membrane preparations with a small number of peptides and bio-
genic amines. These ligand classes are prominent in platyhelminth biology [164, 169, 171, 172],
and there is a strong likelihood that a subset signal through one or more receptors coupled to
either the Gαs or Gαi/o pathways. This would presumably be made apparent by stimulation
77
of basal [cAMP] or inhibition of forskolin (Fk)-stimulated [cAMP] [202] as measured by RIA,
respectively.
Included in this initial screen were the only two ligands definitively coupled to planarian
GPCRs: GYIRFamide and the biogenic amine serotonin (5-HT; 5-hydroxytryptamine). It
was a reasonable assumption that both GYIRFamide and 5-HT would modulate cAMP levels
in a whole organism membrane preparation. We previously deorphanized the D. tigrina recep-
tor GtNPR-1, showing it responded potently to the neuropeptide GYIRFamide in mammalian
cell culture [138]. Chimeric G proteins (Gαqi5 and Gαqo5) were used to divert downstream
GtNPR-1 signaling through the Gαq pathway, suggesting this receptor is Gαi/o-coupled in its
native environment. More recently, a Dugesia japonica 5-HT GPCR has been deorphanized
using Xenopus laevis oocytes [142], and there is long-established evidence of 5-HT stimulation
of cAMP in both S. mansoni [203,204] and other planarian species [205], suggesting that 5HT
acts through one or more Gαs-coupled GPCRs.
Alongside GYIRFamide and 5-HT, we included neuropeptide F (NPF) and octopamine as pu-
tative ligands. NPF has been shown to inhibit Fk-stimulated cAMP production in membranes
isolated from S. mansoni [201]. Given the identification of planarian NPF homologues [171,172],
we hypothesized that this peptide would have a similar inhibitory effect on cAMP levels. The
results of this primary screen show that 10−5M 5-HT drastically stimulates cAMP produc-
tion, while 10−4M GYIRFamide, 10−4M NPF, and 10−4M octopamine inhibit Fk-stimulated
cAMP accumulation in Dugesia membrane preparations (Figure 3.2) to varying degrees. These
changes in [cAMP] can be viewed as the additive response profile of each ligand.
We chose to pursue the response profiles of GYIRFamide and 5-HT. Provided that GtNPR-1 is
a known target of GYIRFamide in D. tigrina, we first examined whether or not this would be
apparent using this novel loss-of-function approach. Given that the inhibition of adenylate cy-
clase by GYIRFamide is less potent than that brought on by NPF, this also serves as validation
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of assay sensitivity. In addition to this proof or principle, we chose to pursue deorphanization
of an orphan S. mediterranea 5-HT receptor, aided by the availability of receptor sequence data
for this species.
Coupling Second-Messenger Assay with RNAi: GtNPR-1 Proof of Principle
Establishing RNAi-mediated Receptor Suppression
Double-stranded (ds) RNA was introduced to isolated D. tigrina colonies using a bacterial-
mediated feeding protocol. Planaria were randomly selected, isolated into treatment groups,
and fed either non-flatworm control dsRNA or GtNPR-1 dsRNA. A 10 day RNAi feeding
cycle consisted of four evenly-spaced feedings, followed by a four-day starvation period. Semi-
quantitative RT-PCR was used to confirm gene knockdown. A small number of planarians were
randomly selected from both experimental and control groups to assay GtNPR-1 suppression,
and the remaining planarians were used for membrane assays. Significant GtNPR-1 knockdown
(> 80%) is consistent and apparent in the experimental group, while GtNPR-1 expression
remains robust in the control group (Figure 3.3) relative to endogenous standard.
Deorphanization via Comparison of Response Profiles
Membranes were prepared from both control and GtNPR-1 dsRNA-fed planarians, and treated
with Fk (10−4M), GYIRFamide (10−4M), and Fk (10−4M) + GYIRFamide (10−4M). RIA
was used to assay cAMP levels corresponding to these treatments. Comparison of the response
profiles of control and RNAi planaria reveals near-complete abolishment of GYIRFamide-evoked
inhibition of Fk-stimulated cAMP in the GtNPR-1 knockdown group (Figure 3.4, Table 3.1).
Overall, GYIRFamide reduces Fk-stimulated cAMP production by an average of ∼ 30% in the
control group, and this inhibition was completely abolished by the suppression of GtNPR-1
expression in the RNAi group. In fact, combined Fk and peptide treatment led to a slight
increase (∼ 2%) in cAMP levels compared to Fk alone. These results confirm that GtNPR-1
is agonized by GYIRFamide and further establish that this receptor is natively coupled to the
Gαi/o signaling pathway.
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In silico Target Selection
The two ligands that most drastically stimulated and inhibited adenlyate cyclase activity in
our primary ligand screen were 5-HT and NPF, respectively. These results were shown to ex-
tend to S. mediterranea (data not shown). To identify and rank 5-HT receptor candidates, a
profile HMM was built with sequences procured from GPCRDB [107]. Training was focused on
62 full-length invertebrate 5-HT and 5-HT-like receptors. This was used to search against S.
mediterranea GPCR sequence datasets [199], and the results were ranked by E-value. The top
10 receptor candidates were used as BLASTp [124] queries against the NBCI “nr” database.
This was used to identify receptors displaying 5-HT receptor homology, and to filter against
receptors that displayed a varied range of biogenic amine GPCR-related homology.
Receptors that survived the BLAST filter were compared to their nearest-related S. mansoni
homologs, each returning either Smp 148210 and Smp 126730 (Table 3.2). While there is a
great deal of bioinformatic evidence to suggest multiple receptor targets for 5-HT, we narrowed
our list to two best-match receptors and selected mk4.001585.00.01 as the first target for RNAi-
based deorphanization. This receptor is tentatively labeled Smed-SER85.
RNAi-based Deorphanization of Planarian 5HT Receptor
Smed-SER85 transcript expression was confirmed via PCR, and knockdown was illicited fol-
lowing the protocol described for GtNPR-1. Similarly, a membrane preparation protocol was
optimized for S. mediterranea and membranes were treated with 10−4 M Fk, 10−4 M 5-HT, 10−4
8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), and 10−4 meta-Chlorophenylpiperazine
(mCPP) (Figure 3.5). 8-OH-DPAT is an agonist of vertebrate 5-HT1A and 5-HT7 receptors,
while mCPP most potently stimulates 5-HT2B and 5-HT2C . This initial profile establishes that
these compounds can modulate cAMP levels in this phylum as well, presumably through the
action of 5-HT receptors.
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Smed-SER85 Mediates Flatworm Motility
The phenotypic effects of Smed-SER85 knockdown were assayed using an automated video
tracking system. Planarian motility was recorded over a 15 minute period after acclimation
of individual worms to the recording well environment. Figure 3.6 shows ∼ 52% decrease in
distance travelled over the recording duration in a comparison of control and Smed-SER85
RNAi worms. This significant decrease in basal motility levels suggests that Smed-SER85
plays an important role in the maintenance of flatworm locomotory behavior. Previous studies
have established the role of serotoninergic signaling in the regulation of flatworm locomotion
[206,207], and this motility assay establishes Smed-SER85 as the only known receptor mediating
such fundamental flatworm behaviors.
3.3 Conclusions
This study shows the utility of joining RNAi with biochemical endpoint assays to as a means of
deorphanizing platyhelminth GPCRs in their native membrane environment. The approach was
first validated using the only deorphanized flatworm neuropeptide GPCR (GtNPR-1), confirm-
ing agonism by GYIRFamide and providing new information about its endogenous G protein
coupling profile. The orphan S. mediterranea GPCR Smed-SER85 was shown to respond to
5-HT, revealing its endogenous G protein pathway and illustrating the usefulness of applying
an in silico strategy to candidate receptor selection. The translational suppression of Smed-
SER85 led to a major decrease in overall flatworm motility. While 5-HT and 5-HT-related
pharmacological agents had been shown to be involved in regulation of locomotory behavior,
this represents the identification of the first receptor that mediates these observations. While
this loss-of-function strategy side-steps some of the concerns and difficulties associated with
heterologous GPCR expression, there is significant room for improving both the sensitivity and
scalability of this assay.
The heavy tissue requirements of the membrane preparation protocols employed introduce
a potential rate-limiting step. Further optimizations of membrane or whole cell preparation
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protocols in this phylum could allow for more efficient and robust pharmacological analysis.
This assay could also conceivably be adapted to higher-throughput platforms, and extended
to include GPCRs that signal through the Gαq pathway. Conveniently, establishing receptor-
specific RNAi in planaria allows for the accumulation of loss-of-function phenotypic data in
parallel to pharmacological data. In this regard, the study of planarians can inform flatworm
parasite biology. Biasing the receptor and ligand pool to those best conserved between parasitic
and free-living flatworms could lead to new targets for chemotherapeutic intervention.
3.4 Materials and Methods
Planarian maintenance protocol
Dugesia tigrina (Ward’s Natural Science, Rochester, NY) and Schmidtea mediterranea colonies
were maintained in the laboratory with a regular feeding cycle. Dugesia tigrina colonies were
fed three times a week, while Schmidtea mediterranea colonies were fed twice a week. Planarians
were randomly selected and isolated in ∼ 50-worm groupings for RNAi feeding cycles and cAMP
assays.
RNA interference
Primers were designed with Primer3 [192] to selectively amplify 300-500 bp fragments of
GtNPR-1 and 5HT receptor candidate Smed-SER85. BLAT [163] was used to check for poten-
tial off-target silencing. A 465 bp fragment of GtNPR-1 was amplified from a full length clone
of Gt-NPR1 housed in pcDNA3.1(+) with the primers 5’-TTGGATCTTTCCAGCGACTCT-3’
(forward) and 5’-ATGGTTCGTTCGACGTTTTC-3’ (reverse). A 388 bp fragment of Smed-
SER85 was amplified from Schmidtea cDNA isolated using RNAqueous (Ambion) and Ret-
roscript (Ambion) with the primers 5’-CTCCGCTTTTAATTGGAGGA-3’ (forward) and 5’-
CTGTTTCTTTTTCCGGGGAT-3’ (reverse). An RNAi control sequence was amplified from
Aedis aegypti cDNA with primers 5’-ACTTCGGCGTCATTTATTGG-3’ (forward) and 5’-
GAAGGGATCATCGAAAACGA-3’ (reverse), corresponding to a 413 bp fragment of a puta-
tive odorant receptor (VectorBase [208] id: AAEL013422). Second-round PCR was performed
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for each target sequence using the original gene-specific primers flanked by Gateway Cloning
system (Invitrogen) recombination sites: 5’-GGGG-attB1-3’ (forward) and 5’-GGGG-attB2-
3’ (reverse). Entry sequences were subcloned into the pPR244 (pDONRdT7) [77] (Appendix
D) destination vector with corresponding attP1 and attP2 recombination sites using the BP
Clonase II (Invitrogen) enzyme mix. Clones were transformed into TOP10 Electrocompetent
E. coli (Invitrogen) and sequence confirmed.
Bacterial-mediated dsRNA feeding
Propagation of RNAi vectors was carried out using competent RNase III-deficient HT115 (DE3)
bacterial cells as previously described [77]. Colonies were scaled in liquid culture (500 ml)
until an OD of 0.3-0.4 was reached, and T7 polymerase activity was IPTG-induced. After 2
hours, cells were pelleted by centrifugation and resuspected in 50 ml of media. This step was
repeated with a resuspension volume of 10 ml. Glycerol stocks of dsRNA-containing bacteria
(665 ul total volume; 20% glycerol) were mixed with 275 ul of blended organic beef liver and
100 ul red blood cells (RBCs). RBCs allowed for visual monitoring of planarian food intake.
Planarians were dark-fed dsRNA-containing bacteria four times over a 10-day timeline with
each feeding separated by a two-day period, and starved for at least four days prior to their
use in experiments.
Semi-quantitative RT-PCR
Total RNA was extracted from individual planaria with RNAqueous (Ambion), followed by
removal of DNA contaminants with TURBO DNase (Ambion). First strand cDNA synthesis
was carried out with the RETROscript kit (Ambion), as part of a two-stage RT-PCR. PCR
optimization was carried out with the QuantumRNA 18S Internal Standards kit (Ambion) per
manufacturer instructions. 18S ribosomal RNA was used as an endogenous standard for nor-
malizing measures of gene expression and reducing sample-to-sample variation. cDNA samples
were used in parallel as templates for multiplex PCR with gene-specific and 18S rRNA primer
pairs. PCR reaction products were visualized on 1.2% electrophoretic gel with the Kodak Gel
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Logic 112 imaging system, and amplicon intensities were analyzed with standard software to
derive relative transcript abundances.
Membrane preparation and cAMP RIA
Planaria were washed twice with cold cAMP buffer containing 50 mM sucrose, 50 mM glycyl-
glycine, 10 mM creatine phosphate, 2 mM MgCl2, 0.5 mM isobutylmethylxanthine (IBMX),
1 mM dithiothreitol (DTT), 0.02 mM EGTA, 10 units/ml creatine kinase, and 0.01% bovine
serum albumin. Worms were kept on ice for 5 min and then homogenized on ice for 2 min with
a Teflon homogenizer. This preparation was centrifuged at 1,000 X g for 5 min, with the pellet
that included cell debris discarded. This centrifugation step was then repeated. The super-
natant was centrifuged at 40,000 X g for 30 min at 4◦C. The supernatant was discarded, and the
membrane-containing pellet was resuspended via sonication in cAMP buffer suplemented with
0.1 mM ATP and 0.1 mM GTP. Total suspension volume was set at 500 ul/sample, such that
each sample would contain cell membranes from ∼ 3 worms. 500 ul aliquots of this membrane
preparation correspond to individual reactions in the cAMP assay.
Samples were incubated with various concentrations (and combinations) of forskolin and/or pu-
tative ligands (peptide or biogenic amine) at 37◦C for 20 min to stimulate cAMP production.
Forskolin and peptide ligands were dissolved in Me2SO, with final reaction mixtures contain-
ing <0.1% Me2SO. Me2SO has no measurable effect on cAMP in this range. Samples were
centrifuged at 3,000 X g for 5 minutes after ligand incubation, and 400 ul of supernatant from
each sample was transferred into a fresh tube. Three reactions was assayed for each treatment
condition, and each reaction was sampled in triplicate. cAMP concentration was determined
with a radioimmunoassay as described previously [209], with a lower detection bound of 1.6
fmol per tube.
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Bioinformatics
A Profile HMM were built using HMMER-2.3.2 [126] using training sequence data from GPCRDB
[107]. Available invertebrate 5-HT full-length receptor sequences were aligned and a profile
HMM was constructed for each using hmmbuild. The model underwent calibration using hmm-
calibrate, with the default parameters. S. mediterranea GPCR sequence datasets [199] were
searched against this subfamily-specific profile HMM using hmmpfam. The resulting hits for
were parsed with a Perl script and ranked according to E-value. The top 10 receptors candidates
were used as BLASTp [124] queries against the NBCI “nr” database, and surving receptors
were similarly searched against the S. mansoni predicted proteome [24].
Phenotypic Assays
Planarian motility was tracked with the Ethovision 3.1 video tracking system (Noldus). Worms
were individually tracked in wells, and allowed to settle for 10 minutes proceeded by a 15 minute
recording period. Worms were recorded in groups of six in a six-well plate platform. Recorded
movement tracks were examined to confirm that the tracking software properly distinguished
the organism from background.
Statistical Analysis
Basal cAMP levels were set as a baseline for individual RIA experiments, and cAMP values
were normalized with respect to the level of Fk-stimulated cAMP (set at 100%). This allowed
us to join datasets from repeated experiments with differing basal cAMP levels due to variance
in the quality and yield of individual membrane preparations. One-way analysis of variance
(ANOVA) was used with Tukey’s post hoc test for multiple comparison analysis of cAMP levels
associated with different treatments. A two-tailed T-test was used for motility comparison
between control and RNAi groups. Significances are reported at P < 0.05, P < 0.01, and P <
0.001.
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3.6 Figures and Tables
A
Blank Fk L Fk+L
Control
Profile
RNA-i (x)
B C D
A B C' D'
I.   If C > A, D ≥ B: L has aggregate stimulatory effect on [cAMP]            
     If C' < C, D' ≤ D: GPCR "x" is L-responsive and G-s coupled
II.  If C ≤ A, D < B: L has aggregate inhibitory effect on [cAMP]
     If C' ≥ C, D' > D: GPCR "x" is L-responsive and G-i coupled
III. If C ≈ A, D ≈ B: L has no net effect on [cAMP]
Figure 3.1 RNAi-based deorphanization approach overview.
The general set of experimental outcomes for an RNAi-based deorphanization experiment focused on
the Gs and Gi pathway are shown. Letters placed within wells represent assayed cAMP levels for
membrane preparations in response to various treatments. Potential results are described with respect
to the notion that a given ligand can act on multiple GPCRs that are not necessarily coupled to the
same G protein (Gs or Gi). Abbreviations: Fk, forskolin; L, ligand; RNAi (x), RNAi preparation with
GPCR “x” knocked down.
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Figure 3.2 cAMP ligand screen
Peptide and biogenic amine ligand screen performed against isolated D. tigrina membranes. RIA cAMP
outputs are shown as mean ± SEM, and asterisks represent statistically significant differences compared
with either control or treatment with Fk alone; * P < 0.05, *** P < 0.001, one-way ANOVA, Tukey
post hoc test. Red bars are compared with Fk treatment: octopamine (OCT), GYRIFamide (GYIRF),
and neuropeptide F (NPF) all inhibit Fk-stimulated cAMP at 100 uM. The green bar is compared
with the control condition: serotonin (5-HT) stimulates basal cAMP. These changes in cAMP are likely
GPCR-mediated, and should therefore be altered in a ligand-specific manner by subtraction of particular
receptor targets from cell membranes via RNAi.
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Figure 3.3 Semi-quantitative PCR reveals GtNPR-1 knockdown.
Lane 1 is a 100 bp DNA ladder, lanes 2-5 represent individual GtNPR-1 dsRNA-fed planarians, and
lanes 6-9 represent control dsRNA-fed planarians. The bottom band (∼ 300 bp) is the 18S internal
standard, and the top band (∼ 400 bp) shows GtNPR-1 expression. The top band disappears in the
experimental group, confirming near abolishment of receptor expression in these worms. Relative band
intensities (GtNPR-1/18S rRNA) for GtNPR-1 RNAi group: 0.44 ± 0.15. Relative band intensities for
control group (band location manually selected): 0.08 ± 0.02. This corresponds to > 80% knockdown
of GtNPR-1 transcript.
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Figure 3.4 RNAi-based GtNPR-1 deorphanization
Treatment groups are Control (control dsRNA) and GtNPR-1 RNAi (GtNPR-1 dsRNA). Treatments
are C (control), Fk (10−4 M forskolin), and Fk + GYIRF (10−4 M forskolin and 10−4 M GYIRFamide).
Each bar is the mean (± SEM) of 3 separate experiments. Basal cAMP levels were set as a baseline for
each individual experiment, and cAMP values were normalized with respect to the level of Fk-stimulated
cAMP (set at 100%). This allowed us to join datasets with differing basal cAMP levels, due to variance
in the quality and yield of individual membrane preparations. Analysis of the raw cAMP values of
individual experiments renders the same results. Asterisks indicate significance at P < 0.001 (***), and
“ns” indicates no significant difference (one-way ANOVA, Tukey post hoc test).
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Figure 3.5 Phamacological response profile of 5-HT receptor agonists.
Treatments applied at 10−4 M: Fk, 5-HT, 08-OH-DPAT, and meta-Chlorophenylpiperazine (mCPP).
This control profile shows that 5-HT and 8-OH-DPAT lead to an overall increase in cAMP, while mCPP
has an overall inhibitory effect on cAMP levels. Treatment groups are compared to control group.
Asterisks indicate significance at P < 0.001 (***) and P < 0.01 (one-way ANOVA, Tukey post hoc test).
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Figure 3.6 Effects of Smed-SER85 suppression on basal motility.
Total locomotory distance calculated over a 15 minute recording period (n=20). Comparison of control
and Smed-SER85 RNAi planarians reveals a > 50% decrease in overall motility (two-tailed t-test, P
< 0.001), suggesting this receptor plays a fundamental role in maintenance of planarian locomotory
behavior.
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EXP Treatment Control GtNPR1 RNAi
C 62.05 ± 2.46 60.83 ± 1.91
1 Fk 102.45 ± 4.06 101.47 ± 1.59
Fk + G 85.02 ± 1.59 ∗∗∗ 103.03 ± 4.27 ns
C 27.88 ± 0.97 33.54 ± 1.27
2 Fk 57.37 ± 2.68 58.78 ± 1.64
Fk + G 48.67 ± 1.23 ∗∗ 57.89 ± 0.93 ns
C 81.49 ± 4.06 55.16 ± 1.60
3 Fk 215.96 ± 10.99 129.79 ± 3.61
Fk + G 195.63 ± 6.17 ∗∗ 132.60 ± 4.62 ns
Table 3.1 RNAi-based GtNPR-1 deorphanization cAMP raw values
RIA-determined cAMP values (pM) are provided for 3 separate experiments (mean± SEM). Treatments:
C (control), Fk (Forskolin), Fk + G (Forskolin + GYIRFamide). The amount of isolated membrane
differs between experiments, as evidenced by basal cAMP levels. This is in part due to differences in
the size, number, and feeding behavior of worm batches used for membrane isolation. Analysis (one-
way ANOVA, Tukey) of these raw datasets establishes abolishment of cAMP inhibition brought on
by GYIRFamide via GtNPR-1 suppression. For each experimental grouping, Fk is compared to Fk +
G. Asterisks indicate significance at P < 0.001 (***), P < 0.01 (**), and “ns” means no significant
difference.
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S. mediterranea 5-HT HMM BLAST S. mansoni PID
mk4.013690.00.01 2.90E-108
mk4.005939.01.01 3.90E-85 * Smp 148210 58%
mk4.011371.00.01 1.20E-71
mk4.001585.00.01 3.00E-70 * Smp 126730 47%
mk4.007388.02.01 9.60E-69 *
mk4.029325.00.01 2.30E-65
mk4.000656.10.01 1.10E-61
mk4.004462.02.01 5.10E-51 * Smp 148210
mk4.011006.00.01 3.30E-50 * Smp 126730
mk4.003202.01.01 1.10E-49
Table 3.2 5-HT candidate receptor selection
Top-ranked 5-HT profile HMM hits are shown with their associated E-values. Receptors that survived
the BLAST filter are marked with an asterisk (*). The nearest related S. mansoni homolog is shown and
% identity (PID) values are printed for the best match to each parasite receptor. Of these two receptors
(shown in bold), mk4.001585.00.01 (Smed-SER85) was selected for RNAi-based deorphanization.
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4 PROF1 Localization in Planaria
The PROF1 receptor family, as a flatworm-specific subset of the notoriously drugable GPCR
superfamily, represents a rational target for anthelmintic drug discovery. As an initial step
towards deciphering the biological functions of these receptors and assaying their potential
exploitability as drug targets, whole mount in situ hybridization (WISH) was used to local-
ize transcript expression for two planarian PROF1 receptors. The overarching motivation is
that the different PROF1 receptors and receptor subtypes are likely to display unique mRNA
expression patterns that will inform us about their cognate ligands and their potential signal
transduction roles with respect to flatworm anatomy.
4.1 Planarian In situ hybridization protocol
PROF1 receptor fragments were PCR amplified with the minimal T7 polymerase promoter se-
quence appended to the 5’ anti-sense primer. Primers for SMDC2955.1: 5’-cgtgcctacctgattccatt-
3’ (forward) and 5’-TAATACGACTCACTATAGGGTACTtttcctcgttgggagatttg-3’ (reverse).
Digoxygenin (DIG)-labeled antisense riboprobes were synthesized using these PCR products
(Roche). Whole-mount in situ hybridization (WISH) was performed at 55◦C in hybridization
solution (50% formamide, 5XSSC, 100 ug/ml yeast tRNA, 100 ug/ml heparin sodium salt,
0.1% Tween-20, 10 mM DTT, 10% dextran sulfate sodium salt). DIG-labeled riboprobe (40
ng/ml) was denatured at 72◦C for 15 min immediately prior to hybridization. BCIP/NBT was
used for chromogenic color development, followed by paraformaldehyde fixation and imaging.
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4.2 PROF1 Localization Results
WISH staining revealed that the expression pattern for SMDC2955.1 (PROF1 group II) is
localized to the planarian nervous system. From this we can conclude that PROF1 receptors
are endoGPCRs expressed in the planarian nervous system, as opposed to chemosensory-type
GPCRs. Further, their cognate ligands likely belong to either the neuropeptide or biogenic
amine receptor families. The former is of greater likelihood, given the relative conservation
of aminergic GPCRs in the metazaoa in comparison to peptidergic GPCRs, and the highly-
diverged nature of this receptor clade. More concrete evidence for the hypothesis that PROF1
receptors respond to neuropeptide ligands comes in the form of the transcript distributions of
very recently identified flatworm-specific peptides [172]. It is also entirely possible that PROF1
ligand(s) have yet to be uncovered. This preliminary result is encouraging, given the likelihood
of functional conservation with respect to schistosome biology, as the parasite nervous system
and neuromusculature is widely recognized as fertile ground for drug targeting [?, 210].
Figure 4.1 Localization of PROF1 transcripts in S. medterranea
(L) The localization of a single PROF-1 subtype II transcript (labeled SMDC2955.1) is shown along
the longitudinal nerve chords (red) and the cerebral ganglion (green). (R) The planarian head region
reveals PROF-1 expression in the cerebral ganglion (green).
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5 CONCLUSIONS
This dissertation describes the successful application of a sophisticated bioinformatics protocol
to comprehensively identify G protein-coupled receptors in two important flatworm species,
the human parasite Schistosoma mansoni and the model planarian Schmidtea mediterranea.
Transmembrane-focused hidden Markov models were used in combination with a set of filters
to mine the genomic assemblies of these organisms for GPCRs. Subsequent rounds of manual
gene curation and homology-based searches against the nucleotide assemblies further expanded
the total receptor count and improved the quality of the underlying gene models. The final
GPCR dataset houses 116 S. mansoni and 333 S. mediterranea GPCRs. Phylogenetic analysis
confirmed the presence of the primary metazoan ‘GRAFS’ families, and revealed large num-
bers of lineage-specific receptors. Among these, the flatworm-specific PROF1 receptors and the
planarian-specific PARF1 receptors represent the largest and most distinct groupings.
Transmembrane-focused SVMs were trained and used to sub-classify a subset of full-length
Rhodopsin and aminergic receptors. Together, these phylogenetic, homology, and machine
learning-based outputs can guide future efforts to identify the cognate ligands of these GPCRs.
To learn more about the potential roles of PROF1 receptors, in situ hybridization was per-
formed in S. mediterranea. The transcript distribution of a representative of PROF1 subtype
II was localized to the nervous system. This and other lines of evidence suggest that these
receptors are endo-GPCRs that likely respond to flatworm-specific peptide ligands. Analysis
of Glutamate GPCRs revealed receptors with non-canonical ligand binding domains that are
likely to exhibit atypical pharmacology or respond to other amino-acid derived ligands. To
support the adoption of planarians as flatworm parasite models, parasite-planarian sequence
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pairs were ranked by shared sequence identity.
In light of the unpredictable nature of heterologous approaches to GPCR deorphanization,
significant steps were taken to validate an RNAi-mediated loss-of-function approach to char-
acterizing GPCRs in their native membrane environment. A membrane preparation protocol
was optimized for use with planaria, and RNAi was used in conjunction with a biochemical
endpoint assay (cAMP RIA) to associate the planarian receptor GtNPR-1 with its neuropep-
tide ligand GYIRFamide. This process also coupled the receptor to its endogenous G protein
signaling pathway (Gαi/o). A small ligand screen of biogenic amines and peptides yielded other
leads for application of this method. Among these, we further bioionformatically ranked and
pursued 5-HT receptors mediating the aggregate stimulatory effects of 5-HT on cAMP levels.
Parallel phenotypic assays revealed that downregulation of Smed-5HT85 significantly decreases
planarian motility.
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APPENDIX A The genome of the blood fluke Schistosoma mansoni
A paper published in the journal Nature 1
Matthew Berriman 2 et al. (Mostafa Zamanian 3,4, and Tim A Day 1,2)
This appendix includes the abstract and selected sections for which I shared primary respon-
sibility in both the underlying analysis and write-up. Supplementary Tables 12, 13, 20, and
Supplementary Figure 4 resulted from the work summarized in these sections.
Abstract
Schistosoma mansoni is responsible for the neglected tropical disease schistosomiasis that affects
210 million people in 76 countries. Here we present analysis of the 363 megabase nuclear
genome of the blood fluke. It encodes at least 11,809 genes, with an unusual intron size
distribution, and new families of micro-exon genes that undergo frequent alternative splicing.
As the first sequenced flatworm, and a representative of the Lophotrochozoa, it offers insights
into early events in the evolution of the animals, including the development of a body pattern
with bilateral symmetry, and the development of tissues into organs. Our analysis has been
informed by the need to find new drug targets. The deficits in lipid metabolism that make
schistosomes dependent on the host are revealed, and the identification of membrane receptors,
ion channels and more than 300 proteases provide new insights into the biology of the life
cycle and new targets. Bioinformatics approaches have identified metabolic chokepoints, and
a chemogenomic screen has pinpointed schistosome proteins for which existing drugs may be
1Reprinted with permission of Nature: Vol 460 | 16 July 2009 | doi:10.1038/nature08160
2Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SA, UK
3Department of Biomedical Sciences, Iowa State University, Ames, IA USA
4Interdepartmental Neuroscience Program, Iowa State University, Ames, IA USA
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active. The information generated provides an invaluable resource for the research community
to develop much needed new control tools for the treatment and eradication of this important
and neglected disease.
GPCRs, ligand-gated and voltage-gated ion channels
GPCRs, ligand-gated and voltage-gated ion channels are targets for 50% of all current phar-
maceuticals [211]. At least 92 putative GPCR-encoding genes are present (Supplementary
Table 12), the bulk (82) of which are from the rhodopsin family. The largest groups are the
α-subfamily (30), which includes amine receptors, and the β-subfamily (24), which contains
neuropeptide and hormone receptors. The diversity of the former subfamily underlines the
wide range of potential amine/neurotransmitter reactivities of schistosomes, but the tentative
identities assigned need to be confirmed by functional studies, as has already been performed
for a histamine receptor [139]. Schistosomes detect chemosensory cues, but a large, unique
clade of the mediating receptors was not found. However, the 26 ‘orphan’ rhodopsin family
GPCRs may include proteins with this role. Outside the large rhodopsin family, representatives
from each of the smaller families of GPCRs, glutamate family (2), frizzled family (3), and the
secretin/adhesion family (4) are present.
Each of the three major ligand-gated ion channel families- the Cys-loop family, glutamate-
activated cation channels, and ATP- gated ion channels- are represented in the schistosome
genome. Of the 13 Cys-loop family ligand-gated ion channels, nine encode nicotinic acetyl-
choline receptor subunits (Supplementary Fig. 4 and Supplementary Table 13). The remaining
four anion channel subunits group among GABA (c-aminobutyric acid), glycine and glutamate
receptors, but it is not possible to assign precise identities. The seven schistosome glutamate-
activated cation channels comprise at least two sequences from each of the three common
sub-groupings. The presence of a functional P2X receptor for ATP- mediated signalling in
schistosomes was already known [212], and the data here show at least four more.
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Voltage-gated ion channels generate and control membrane potential in excitable cells, and are
central to ionic homeostasis. There are examples of successful drugs targeting voltage-gated
sodium, potassium and calcium channels [213]. Although voltage-gated sodium channels were
not found, at least 41 members from each of the major six transmembrane (6TM) and four
transmembrane (4TM) families of potassium channels (Supplementary Table 14) are present.
The 6TM voltage-gated potassium channel family (20 members) is the largest, including the
well-characterized Kv1.1 channel found in nerve and muscle of adult schsitosomes [214]. Other
classes of 6TM potassium channels include the KQT channels, large calcium-activated channels,
small calcium-activated channels, and cyclic-nucleotide-gated groups. This last group, compris-
ing eight members, is most often associated with signal transduction in primary olfactory and
visual sensory cells (Caenorhabditis elegans has only five; [215]). S. mansoni possesses six 4TM
inward-rectifying TWIK-related potassium channels (about 46 in C. elegans). There are four
α and two β subunits of voltage-gated calcium channels in schistosomes, and a β subunit is
implicated as a molecular target of the anti-schistosomal praziquantel [216].
Neuropeptides
Thirteen putative neuropeptides were identified (Supplementary Table 20), indicating that
schistosomes may have much greater diversity than the two described previously. Apart from
the neuropeptide Fs (NPFs), most are apparently restricted to the Platyhelminthes- their ab-
sence from humans making them a credible source of anthelmintic drug leads. The predicted
product of npp-6 (the amidated heptapeptide AVRLMRLamide) resembles molluscan myomod-
ulin, whereas the two NPP-13 peptides show 100% carboxy-terminal identity with vertebrate
neuropeptide-FF-like peptides (peptides ending with a C-terminal sequence PQRFamide); nei-
ther of these has previously been reported in any non-vertebrate organism. The discovery of
a second NPF (NPP-21b) as well as the known NPP-21a [201] is reminiscent of the vertebrate
neuropeptide Y (NPY) superfamily, and strengthens the argument that NPFs and NPYs have
a common ancestry.
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GeneID Top BLAST % ID E-Value Final Annotation TreeFam
Glutamate Activated Cationic Channels
NMDA
Smp 126350 RF:XP 321646.2 56 4.80E-180 Glutamate Receptor, NMDA TF314731
Smp 147390 RF:XP 971730.1 36 4.60E-121 Glutamate Receptor, NMDA TF314731
Smp 126350 RF:XP 321646.2 56 4.80E-180 Glutamate Receptor, NMDA TF314731
Smp 147390 RF:XP 971730.1 36 4.60E-121 Glutamate Receptor, NMDA TF314731
Kainate
Smp 140920 GB:BAC06343.1 64 6.80E-120 Glutamate Receptor, Kainate TF315232
Smp 147430 RF:XP 966711.1 54 9.50E-136 Glutamate Receptor, Kainate TF315232
Smp 153780 RF:XP 611666.2 37 3.90E-124 Glutamate Receptor, Kainate TF315232
AMPA
Smp 133920 RF:XP 787239.1 30 2.70E-034 Glutamate Receptor, AMPA TF315232
Smp 023290 RF:XP 787239.1 29 3.00E-039 Glutamate Receptor, AMPA TF315232
Cys-Loop Family
Nicotinic Acetylcholine Receptor Subunits
Smp 132070.1 GB:ABA60381.1 51 2.80E-086 nAChR subunit TF315605
Smp 132070.2 GB:ABA60381.1 51 2.80E-086 nAChR subunit TF315605
Smp 031680 GB:AAR84361.1 99 0 nAChR subunit (ShAR1alpha) TF315605
Smp 037960 GB:ABA60381.1 50 2.80E-105 nAChR subunit TF315605
Smp 142690 GB:ABA60385.1 42 1.20E-081 nAChR subunit (ShAR1beta2) TF315605
Smp 142700 GB:ABA60381.1 49 3.10E-102 nAChR subunit TF315605
Smp 157790 GB:ABA60385.1 57 5.80E-098 nAChR subunit TF315605
Smp 176310 GB:ABA60381.1 48 3.80E-095 nAChR subunit TF315605
Smp 180570 GB:ABA60386.1 37 6.20E-062 nAChR subunit TF315605
Smp 130390 GB:ABA60386.1 76 4.40E-045 nAChR subunit TF315605
Smp 139330 GB:AAR84362.1 97 0 nAChR subunit (ShAR1beta) TF315605
Smp 101990 RF:NP 000070.1 30 6.30E-025 nAChR subunit TF315605
Non-nicotinic Cys-loop Receptor Subunits
Smp 015630 GB:AAM23270.1 42 2.70E-065 Cys-loop LGIC Subunit TF315453
Smp 096480 SP:O75311 37 2.30E-068 Cys-loopLGIC Subunit TF315453
Smp 099500 RF:XP 974894.1 36 3.60E-031 Cys-loop LGIC Subunit TF315453
Smp 176730 RF:NP 001024077.1 51 1.20E-028 Cys-loop LGIC Subunit TF315453
Smp 104890 SP:P57695 47 2.40E-062 Cys-loop LGIC Subunit TF315453
Table A.1 Summary of Ligand-Gated Ion Channels (LGIC)
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GeneID Top BLAST % ID E-Value Final Annotation TreeFam
ATP gated ion channels
P2X
Smp 099640 GB:CAH04147.1 48 2.00E-097 P2x Receptor Subunit TF328633
Smp 176860 GB:CAH04147.1 46 1.80E-073 P2x Receptor Subunit TF328633
Smp 179310 GB:CAH04147.1 100 5.60E-164 P2x Receptor Subunit TF328633
Smp 114060 GB:AAX11263.1 43 1.60E-031 P2x Receptor Subunit TF328633
Smp 089780 RF:NP 990079.1 37 5.50E-024 P2x Receptor Subunit TF328633
Smp 005030 GB:AAX11263.1 100 1.20E-035 P2x Receptor Subunit TF328633
Other
Cyclic-nucleotide-gated cation channel
Smp 056560 RF:XP 967432.1 50 1.10E-055 TF318250
Smp 152480 RF:XP 395071.2 54 5.80E-146 TF318250
Smp 152500 RF:XP 314248.2 66 7.50E-066 TF318250
Smp 155040 RF:XP 554755.1 43 8.90E-115 TF318250
Smp 194700 SP:Q90805 53 6.50E-166 TF318250
Amiloride-sensitive sodium channel
Smp 058270 TF330663
Smp 083980 TF317359
Smp 175020 TF317359
Smp 052630 GB:AAK20896.1 24 6.90E-014 TF317359
Smp 162680 GB:AAF80601.1 25 2.20E-017 TF317359
Smp 093210 GB:AAF80601.1 22 2.60E-026 TF317359
Smp 180260 GB:AAK20896.1 26 2.20E-012 TF317359
Table A.2 Summary of Ligand-Gated Ion Channels (LGIC)- Continued
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GeneID Annotation TreeFam
6TM K+ Channels
SMP 081250 voltage-gated potassium channel TF313103
SMP 129380 voltage-gated potassium channel TF313103
SMP 136440 voltage-gated potassium channel TF313130
SMP 035160 voltage-gated potassium channel TF313103
SMP 035180 voltage-gated potassium channel TF315186
SMP 035870 voltage-gated potassium channel TF313103
SMP 146620 voltage-gated potassium channel TF313130
SMP 148670 voltage-gated potassium channel TF313130
SMP 151810 voltage-gated potassium channel TF313130
SMP 152350 voltage-gated potassium channel TF313130
SMP 063930 voltage-gated potassium channel SKv1.1 TF313103
SMP 157490 voltage-gated potassium channel TF313130
SMP 069240 voltage-gated potassium channel TF313103
SMP 160780 voltage-gated potassium channel TF313103
SMP 161140 voltage-gated potassium channel TF313130
SMP 163090.1 voltage-gated potassium channel TF352511
SMP 163090.2 voltage-gated potassium channel TF352511
SMP 094560 voltage-gated potassium channel TF313103
SMP 121190 voltage-gated potassium channel TF313103
SMP 194710 voltage-gated potassium channel TF313103
SMP 144310 voltage-gated potassium channel, KQT TF315186
SMP 144310 voltage-gated potassium channel, KQT TF315186
SMP 008170 calcium-activated potassium channel, large conductance TF313103
SMP 161450 calcium-activated potassium channel, large conductance TF315015
SMP 166620 calcium-activated potassium channel, large conductance TF313947
SMP 166910 calcium-activated potassium channel, large conductance TF314283
SMP 156150 calcium-activated potassium channel, small conductance TF315015
SMP 056560 cyclic-nucleotide-gated cation channel TF318250
SMP 152480 cyclic-nucleotide-gated cation channel TF318250
SMP 152500 cyclic-nucleotide-gated cation channel TF318250
SMP 155040 cyclic-nucleotide-gated cation channel TF318250
SMP 194700 cyclic-nucleotide-gated cation channel TF318250
SMP 153100 cyclic-nucleotide-gated cation channel, hyperpolarization-activated TF318250
SMP 168880 cyclic-nucleotide-gated cation channel, hyperpolarization-activated TF318250
SMP 174860 cyclic-nucleotide-gated cation channel, hyperpolarization-activated TF318250
Table A.3 Summary of Voltage-Gated and Other Ion Channels
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GeneID Annotation TreeFam
4TM K+ Channels
SMP 127170 twik family of potassium channels-related TF316115
SMP 034850 twik family of potassium channels-related TF313947
SMP 141570 twik family of potassium channels-related TF316115
SMP 046640 twik family of potassium channels-related TF316115
SMP 151120 twik family of potassium channels-related TF313947
SMP 155970 twik family of potassium channels-related TF313947
Voltage-Gated Ca2+ Channels
SMP 020270 high voltage-activated calcium channel Cav1 TF312805
SMP 159990 high voltage-activated calcium channel TF312805
SMP 020170 high voltage-activated calcium channel Cav2A TF312805
SMP 004730 high voltage-activated calcium channel Cav2B TF312805
SMP 135140 high voltage-activated calcium channel beta subunit CavB1 TF316195
SMP 141660 high voltage-activated calcium channel beta subunit CavB2 TF316195
SMP 141780 Four domain-type voltage-gated ion channel alpha-1 subunit TF312843
Voltage-Gated Cl- Channels
SMP 058360.1 chloride channel protein TF313867
SMP 058360.2 chloride channel protein TF313867
SMP 071970 chloride channel protein TF313867
Table A.4 Summary of Voltage-Gated and Other Ion Channels- Continued
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APPENDIX B Yeast GPCR Assay
This appendix contains data related to progress towards the yeast-based deorphanization of
a Schistosoma mansoni neuropeptide-like GPCR (Smp 011940). Figure B.1 provides a com-
parison of the endogenous (left) and modified (right) pathways that allow for these strains to
be used for receptor deorphanization. The first candidate receptor chosen for this approach
was originally identified in a regular expression-driven ORF screen of GPCR homologues in S.
mansoni, and exhibits a great deal of sequence similarity with an allatostatin-responsive GPCR
(Figure B.2).
GpaI (α)
α-factor
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GDPGTP
Ste4 (β) Ste18 (γ)
Ste11 (MEKK)
Ste7 (MEK)
Fus3 (MAPK)
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Ste4 (β) Ste18 (γ)
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Figure B.1 Heterologous GPCR expression in yeast.
105
Figure B.2 Smp 011940 sequence alignment.
Smp 011940 (0029329) is aligned with an allatostatin receptor from Periplaneta americana (AAK52473).
Yellow and green signify sequence identity and sequence similarity, respectively.
Full-length GPCR sequence characterization with 5’,3’-RACE PCR.
5’,3’-Rapid Amplification of cDNA Ends (RACE) PCR was used to elucidate full-length gene
structure, and to establish with certainty the coding sequence of the GPCR to be heterologously
expressed. Poly A+ RNA was extracted from adult S. mansoni tissue using TRI Reagent
(Sigma) and Dynabead’s mRNA Purification Kit (Dynal). This mRNA was used to synthesize
cDNA with SMART RACE cDNA Amplification Kit (BD Biosciences). Gene specific primers
were designed from ORF sequences and used for 5’ and 3’ RACE PCR in conjunction with
the cDNA templates. Reactions were visualized on 1.2% agarose gel. Discrete amplicons were
excised from gel, purified, and subcloned into pGEM-T Easy Vector (Promega). The resulting
construct was transformed into JM109 competent Escherichia coli (Promega). Individual clones
identified by a blue-white colony screen were filtered with colony PCR, and positive clones were
cultured in LB broth overnight. Plasmic DNA was purified with the Wizard Plus SV Miniprep
kit (Promega) and sequence confirmed. The final consensus sequence is shown in Figure B.3.
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Sub-cloning receptor coding sequence into yeast expression vector
The Smp 011940 coding sequence was sub-cloned into the yeast expression vector Cp4258 (2µ
ori AmpR LEU2 REP3 PGK-promoter-MFα1-(1-89)) [217, 218]. In the resulting construct,
GPCR expression is driven by the PGK promoter, while the 89 amino acid Mfα1-leader se-
quence is fused to the receptor N terminus to promote GPCR export to the cell membrane [219].
Smp 019940 (in pcDNA3.1) was used as a template in a two-step PCR that added a 6-mer
spacer and NcoI and XbaI restriction sites to the 5’ and 3’ ends of the coding sequence, respec-
tively. The complete coding sequence was then ligated into Cp4258. The resulting construct
was transformed into JM109 competent Escherichia coli (Promega). Individual clones were
screened with a colony PCR, and positive clones were cultured in LB broth overnight. Plasmid
DNA was purified with the Wizard Plus SV Miniprep kit (Promega) and sequenced. A perfect
clone was identified, and used for yeast transformation.
Transformation of yeast with recombinant plasmid.
Cy14083 cells were grown in 10 mL YPD broth overnight (30◦C, 250 RPM), achieving an
optical density (OD600) of about 1. The culture was scaled up by inoculation in 300 mL YPD
in a 1 L flask until OD600 measures fell in the 0.3-0.5 range. The sample was centrifuged at
4,000 x g for 5 min and resuspended in 10 mL H20. Another centrifugation step was performed
at 5,000 x g for 5 min, the pellet was resuspended in 10 mL buffered lithium solution (1 mL
1M LiAc, 1 mL 10X TE and 8 mL H20) and incubated for 1 hr at 30
◦C. Carrier ssDNA
(Salmon sperm) was boiled for 10 minutes and left to cool on ice for 45 min. 200 ug carrier
ssDNA and 1 ug of recombinant plasmid (Smp 0119949‖Cp4258) was added to a sterile 1.5
mL tube. 200 uL of yeast suspension was added, followed by 1.2 mL of PEG 4000 solution
(1 mL 10X TE, 1 mL 10X LiAc, 8 mL 50% PEG 4000). The mixture was quickly vortexed
and incubated for 30 min at 30◦C (250 RPM). Cells were heat shocked at 42◦C for 15 min and
placed in the microcentrifuge for 5 sec. 500 uL was diluted in 1 mL 1X TE, and 200 uL of the
dilution were spread on selective (-LEU) plates. Plates were incubated for 2-4 days at 30◦C
until transformants appeared. Colonies were inoculated in 2 mL -LEU broth and incubated for
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20-24 hrs at 30◦C. Yeast genomic DNA was isolated and used in a PCR screen with primers
specific for Smp 019940. Four positive colonies were propagated and stored for later use in
functional assays.
Figure B.3 Full-length gene transcript of Smp 011940.
As revealed by RACE PCR, the Smp 011940 transcript is 2044 nucleotides in length and contains a
1248 nucleotide open reading frame encoding a 416 amino acid peptide.
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APPENDIX C PROF1 Primers and RT-PCR
S. mansoni and S. mediterranea PROF1 primers
> S. mansoni:
SMP084270
F: 5’ atgataagtatgaactcaagtgaattaatttttactg 3’ (Tm=57)
R: 5’ tcagtaattgtggcctgatacaacgct 3’ (Tm=58)
Predicted length: 1,107 bp (full-length)
SMP041880
F-primer: 5’ atgttacataatactacaactatagattatagtcagttagt 3’ (Tm=59)
R-primer: 5’ tcaatcttcagttctttggggtctatgca 3’ (Tm=59)
Predicted length: 1,026 bp (full-length)
> S. mediterranea: (Tm: 59-60 C for all primers)
SMDC6472.1
F: 5’ tgcaacaaatggtgacgttt 3’ / R: 5’ ggcaaggtagagatggcaaa 5’
Predicted length: 534
F: 5’ tgtgccaaaaagaactcctg 3’ / R: 5’ taaaaccggaagctgtgcat 5’
Predicted length: 1007
SMDC8510.2
F: 5’ cagcccttgggatttattga 3’ / R: 5’ gcggccaaaatatagcaaaa 5’
Predicted length: 446
F: 5’ gcattcgttttcccagtgat 3’ / R: 5’ cttggacttgtgggtgcttt 5’
Predicted length: 956
SMDC8510.3A
F: 5’ ccaaactccatgaccgaact 3’ / R: 5’ aggatccgcaaaaggagaat 5’
Predicted length: 486
F: 5’ aacaacgggcaatactctcg 3’ / R: 5’ cgcaatattttgctcagcttc 5’
Predicted length: 1009
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SMDC14380.2
F: 5’ ccaaactccatgaccgaact 3’ / R: 5’ aggatccgcaaaaggagaat 5’
Predicted length: 493
F: 5’ aacaacgggcaatactctcg 3’ / R: 5’ cgcaatattttgctcagcttc 5’
Predicted length: 1026
SMDC504.1
F: 5’ taggagctctggcatttgct 3’ / R: 5’ gccaataaaccgcagttagc 5’
Predicted length: 433
F: 5’ tcgacttgtcaaatgtcaaagg 3’ / R: 5’ gaggataatgtcggttttgaaca 5’
Predicted length: 1042
SMDC1889.2
F: 5’ gccaattgtaccatgtgctg 3’ / R: 5’ aaaattcgaatggctgatcg 5’
Predicted length: 425
F: 5’ tccttgggatttattggttcc 3’ / R: 5’ aaaattcgaatggctgatcg 5’
Predicted length: 1039
SMDC15273.1
F: 5’ aggcgaactacgcgttcata 3’ / R: 5’ ccccataagtccacgaagaa 5’
Predicted length: 411
F: 5’ ggcgaactacgcgttcatag 3’ / R: 5’ tcccgttaaaatacgaacgaa 5’
Predicted length: 1031
SMDC7587.4
F: 5’ tgtggtgcatttctcatggt 3’ / R: 5’ ttgcaaaaactaacgccaca 5’
Predicted length: 460
F: 5’ tgatctatatatgccaagatcagc 3’ / R: 5’ aaagattttgttaatttcgtcagaaaa 5’
Predicted length: 1001
SMDC2411.1
F: 5’ ttgtcgctgtggttggaata 3’ / R: 5’ aattttcgagctcctgttgc 5’
Predicted length: 499
F: 5’ ttgtcgctgtggttggaata 3’ / R: 5’ aacgaccggaagtggattc 5’
Predicted length: 1059
SMDC2955.1
F: 5’ acgataagtggggcattgag 3’ / R: 5’ tttcctcgttgggagatttg 5’
Predicted length: 495
F: 5’ cgtgcctacctgattccatt 3’ / R: 5’ tttcctcgttgggagatttg 5’
Predicted length: 949
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SMDC5598.1A
F: 5’ tttcctgcatttggtcttcc 3’ / R: 5’ cgcaatttccctgtcgtaat 5’
Predicted length: 500
F: 5’ ccgttaatgagttgccttgg 3’ / R: 5’ cgaaagttcggataacgtgaa 5’
Predicted length: 905
SMDC4570.1
F: 5’ ttcacgattctgttggcttg 3’ / R: 5’ tgatactgatgctggggtca 5’
Predicted length: 505
F: 5’ caagtgatgaatccccgaat 3’ / R: 5’ atgctggggtcaccaataac 5’
Predicted length: 904
SMDC5598.1B
F: 5’ ggtgagtagggccctgtgta 3’ / R: 5’ tacgccaagatgtggggtat 5’
Predicted length: 528
F: 5’ ggtgagtagggccctgtgta 3’ / R: 5’ ggtagcatatgaacattaaggtgtg 5’
Predicted length: 942
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RT-PCR Results
Performed using primer set two (400-600 bp products)
Reaction component V (uL)
Primer 1 (10 uM) 3.0
Primer 2 (10 uM) 3.0
cDNA template 4.0
10X Buffer 5.0
MgCl2 (50 mM) 2.0
dNTP (10 mM) 1.0
H2O 31.5
Platinum Taq 0.5
Total volume 50.0
Stage Temp Time
Denature 94.0 ◦C 2:00
Denature 94.0 ◦C 0:30
Anneal 55.0 ◦C 0:30
Extented 72.0 ◦C 1:00
x45
Hold 4.0 ◦C ∞
Table C.1 PROF1 RT-PCR conditions
PCR reaction (left), PCR thermocycler conditions (right). Template: S. mediterranea cDNA
Figure C.1 S. mediterranea PROF1 RT-PCR.
Lanes 1 and 15 are low DNA mass ladder. Lanes 2-14 are visualized PCR reactions with PROF1 primers
corresponding to (in order): SMDC6472.1, SMDC8510.2, SMDC14380.2, SMDC8510.3A, SMDC,
SMDC1889.2, SMDC15273.1, SMDC7587.4, SMDC2411.1, SMDC2955.1, SMDC5598.1A, SMDC4570.1,
and SMDC5598.1B. Although spurious products can be seen in some lanes, correct-sized amplicons were
present for all putative PROF1 receptors that were PCR amplified.
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APPENDIX D RNAi vector
T7 term = 560-607 
T7 = 612-631 
AttP2= 760-992 
AttP1= 2941-3172 
T7= 3193-3212 
T7 term= 3217-3262 
;:: So 2"1-
KanR 
pUC Ori 
pPR244 (pDONRdT7) ccdB 
Approx. 500 ng of purified plasmid pPR244 was blotted onto Whatman filter paper. This 
plasmid should ONLY be transformed into DB3.1 cells or ccDB Survival2T1R Competent Cells 
(Invitrogen) and maintained with Kanamycin (2sug/ml) and Chloramphenicol (sOug/ml). 
A Gateway BP reaction must be used to insert cDNAs. After the BP reaction, transform into a 
standard cloning strain (ie. DHsalpha) and select ONLY with Kanamycin . ./ 
The circle indicates the location of where the DNA was placed onto the filter paper. Just cut out the 
circle and place it in a microfuge tube with 100 ul or so of TE Buffer. The DNA will elute from the filter 
paper into the TE. After a couple of hours you can use a few ul to transform the bacteria and you 
should be on your way. Remem ber to use ON LY the correct bacterial strain plus both ofthe 
antibiotics (Kan + Chloramphenicol). You have a ton of DNA blotted onto that filter paper so you 
should have no problem. Best Wishes! 
Figure D.1 RNAi vector pPR244 (pDONRdT7).
Two T7 RNA polymerase promoters are flanked by two class I T7 transcriptional terminators to improve
transcription efficiency. A gene fragment is subcloned between the attP1 and attP2 recombination sites,
and the construct is transformed into RNase-III deficient bacteria with IPTG-inducible T7 polymerase
activity to generate target-s ecific dsRNA.
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APPENDIX E cAMP Assay Optimization
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Figure E.1 Membrane preparation optimization with cAMP RIA.
This sample optimization experiment was performed using a D. tigrina membrane preparation, after
alteration of a S. mansoni membrane preparation protocol. Establishes that DMSO is safe to use as a
solvent at the concentrations used in experiments. Establishes that 10−4 M forskolin provides a more
robust cAMP range, and allows for the measurement of NPF inhibition of cAMP with better resolution
than forskolin used at 10−5 M. Confirms significant 5-HT stimulation of cAMP at 10−5 M, even as 10−4
M 5-HT membrane treatments have been previously published.
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APPENDIX F PERL Code
This appendix contains Perl source code used in the completion of this work. This includes
scripts for extracting transmembrane domains, generating SVM feature vectors, calculating
position-specific entropy in multiple sequence alignments, and parsing Blast output files.
TM extraction
#Author: Mostafa Zamanian (mostafaz@iastate.edu)//Iowa State University
#This script streams in two input files:
#1) FASTA-formatted sequence file (with no special characters)
#2) Corresponding HMMTOP output file (generated from 1)
#And generates two output files:
#1) FASTA-formatted sequence file housing TM-only sequences
#2) CVS-formatted spreadsheet file housing TM frequency distribution
#!/usr/bin/perl
use strict;
use warnings;
#Processes FASTA-formated sequence file
open(FILE, "X.fasta") or die("Unable to open file");
my $a;
while ($_ = <FILE>) {
if ($_ =~ />/) {
chomp $_;
$_=$_."&";
}
chomp $_;
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$_ =~s/\s//g;
$a.=$_;
}
$a =~s/>/\&>/g;
$a = $a."&";
#Processes corresponding HMMTOP output file
open(FILE2, "X_HMMTOP.out") or die("Unable to open file");
my $b;
while ($_ = <FILE2>) {
chomp $_;
$_ = $_."\*";
$b.=$_;
}
my $b2 = $b;
#Creates output files
open(OUTFILE, ">X_TMextract.fasta");
open(OUTFILE2, ">X-TMcount.csv");
my @TMcounter;
#Regular expression used to parse and identify headers-sequences pairs
while ($a =~ /\>(.*?)\&([A-Z|\*]{30,})\&/g){
my $geneid = $1;
my $seq = $2;
my $geneid2 = substr($geneid, 0, 99);
#Regular expresion used to identify the HMMTOP coordinate line
#Extract and concatenate TM domains if TM-count is 3-15
if ($b2 =~ /($geneid2)\s+[A-Z]{2,3}\s+([3-9]|1[0-5])\s+(\d+.*?)\*/g){
my $TMtemp = $2;
push @TMcounter, $TMtemp;
my $COOR = $3;
my $i = 1;
my @TMaa = ’’;
while ($COOR =~ /(\d+)\s+(\d+)/g){
my $CR1 = $1;
my $CR2 = $2;
#+-5 aa
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my $TMaatemp = substr ($seq,$CR1-6,$CR2-$CR1+11);
push @TMaa, $TMaatemp;
$i = $i+1;
}
while ($geneid =~ /(.*?)\s/) {
$geneid = $1;
}
#Prints TM-only sequences to FASTA file
print OUTFILE ">",$geneid,"-TM:",$TMtemp,"\n";
print OUTFILE join "", @TMaa;
print OUTFILE "\n";
}
}
#Hash that maps TM numbers to their frequency
my %TM_counters;
for (@TMcounter){
$TM_counters{$_}++;
}
#Prints hash in CSV table format
while (my ($key, $value) = each %TM_counters) {
my $output = "$key ===> $value";
print $output, "\n";
print OUTFILE2 "$key,$value";
print OUTFILE2 "\n";
}
close OUTFILE;close OUTFILE2;
TM extraction: joining of TM domains with character barrier
#Adds special character "-" between concatenated TM domains
#Required for SVM feature vector generation for model T7
#Swap first line for second in previous script:
my $TMaatemp = substr ($seq,$CR1-6,$CR2-$CR1+11);
my $TMaatemp = "-".substr ($seq,$CR1-3,$CR2-$CR1+5)."-";
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SVM dipeptide frequency feature vector construction: full-length model (FL)
#This script streams one input file (FASTA):
#1) Sequence file (with no special characters) with full-length seqs
#And generates one output file (txt):
#1) 400-element frequency vectors taken over each full-length sequence
#!/usr/bin/perl
use strict;
use warnings;
#Declare amino acid alphabet in array form
my @aa1 = ("A","C","D","E","F","G"..."Q","R","S","T","V","W","Y");
my @aa2 = ("A","C","D","E","F","G"..."Q","R","S","T","V","W","Y");
my $z;
my @seqnames;
my @seqs;
#Read in sequence file
while ($_ = <>) {
if ($_ =~ />/) {
$_=$_."*";
}
chomp $_;
$z.=$_;
}
$z =~s/\s//g;
$z =~s/>/\*>/g;
$z = $z."*";
my $z2=$z;
my $z3=$z;
#Hash associating amino acids with numbers (1-20)
my %AA_numbering = (
’A’ => ’1’, ’C’ => ’2’, ’D’ => ’3’, ’E’ => ’4’, ’F’ => ’5’,
’G’ => ’6’, ’H’ => ’7’, ’I’ => ’8’, ’K’ => ’9’, ’L’ => ’10’,
’M’ => ’11’, ’N’ => ’12’, ’P’ => ’13’, ’Q’ => ’14’, ’R’ => ’15’,
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’S’ => ’16’, ’T’ => ’17’, ’V’ => ’18’, ’W’ => ’19’, ’Y’ => ’20’,);
#Generate duplet hash by first generating a duplet array
my @duplet_array;
my $i=0;
for ($i=0; $i<20; $i++){
my $one = $aa1[$i];
my $j=0;
for ($j=0; $j<20; $j++){
my $two = $aa2[$j];
my $onetwo = $one.$two;
push @duplet_array, $onetwo;
}
}
#Create a seed hash, mapping every aa pair to numbers 1-400
my %AA_duplet_numbering ;
my $k=1;
for (@duplet_array) {
$AA_duplet_numbering{$_}=$k;
$k = $k +1;
}
#Extract filename
my $ARGV2=’’;
while ($ARGV =~/(.*?)\.fasta/g){
$ARGV2=$1;
}
#Declares feature vector output file
open(OUTFILE, ">$ARGV2\_FV.txt");
#***
#Reads in and processes individual sequences
while ($z2 =~ />(.*?)\*([ACDEFGHIKLMNPQRSTVWY-]+)\*/g) {
my $seqnumber = $1; #sequence label
my $sequence1 = $2; #raw sequence
my $seq_length = length($sequence1); #sequence length
#Reads in aa duplets in both frames and adds them to vector
my @duplets;
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while ($sequence1 =~ /([ACDEFGHIKLMNPQRSTVWY]{2})/g) {
push @duplets, $1;
}
my $sequence2 = substr ($sequence1,1,);
while ($sequence2 =~ /([ACDEFGHIKLMNPQRSTVWY]{2})/g) {
push @duplets, $1;
}
#Creates hash that maps duplets to their frequency
my %duplet_counter;
for (@duplets) {
$duplet_counter{$_}++;
}
my @printarray2;
while (my ($key, $value) = each %duplet_counter) {
my $output = "$key ===> $value";
push @printarray2, $output;
}
#Sorts duplets alphabetically
my @sorted2 = sort {$a cmp $b} @printarray2;
print join "\n", @sorted2; #prints progress
#Creates ordered frequency array
my @AA_duplet_ordered;
for (@duplets) {
push @AA_duplet_ordered, $AA_duplet_numbering{$_};
}
#Creates ordered hash that maps duplet numbers to frequency
print "\n","AA_duplet_numb => frequency:","\n";
my %duplet_counterb;
for (@AA_duplet_ordered) {
$duplet_counterb{$_}++;
}
print OUTFILE "x "; #where x is an integer- typically 0
#Orders hash keys into new array
my @duplet_counterb_temp = sort {$a <=> $b} (keys %duplet_counterb);
for (@duplet_counterb_temp) {
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my $key = $_; #dipeptide key
my $value = $duplet_counterb{$_}; #frequency value
my $valuef = $value/($seq_length-1); #converts frequencies to proportions
print OUTFILE "$key:$valuef "; #prints final fv values to output file
}
print OUTFILE "\n";
}
close (OUTFILE);
SVM dipeptide frequency feature vector construction: T1 model
#This script streams one input file (FASTA):
#1) Sequence file (with no special characters) with full-length seqs
#And generates one output file (txt):
#1) 400-element dipeptide frequency vector for each sequence
#FVs calculated over length of concatenated TM domains
#Same source code as previous script
SVM dipeptide frequency feature vector construction: T7 model
#This script streams one input file (FASTA):
#1) TM-only sequence file with TM borders marked
#And generates one output file (txt):
#1) 2800-element dipeptide frequency vector for each sequence
#Ordered concatenation of 400-element FVs calculated for each TM
#Replace everything past the line "#***" in FL script
#Reads in and processes individual sequences
while ($z2 =~ />(.*?)\*([ACDEFGHIKLMNPQRSTVWY-]+)\*/g){
my $seqnumber = $1;
my $sequence1 = $2;
#Reads in individual TM partitions in order
my @sequencepartitions;
while ($sequence1 =~ /([ACDEFGHIKLMNPQRSTVWY]+)/g){
push @sequencepartitions, $1;
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}
my $x=0;
for (@sequencepartitions) {
print "\n","Duplets","\n";
my @duplets =();
my $sequence1a = $_;
my $seq_length1a = length($sequence1a);
while ($sequence1a =~ /([ACDEFGHIKLMNPQRSTVWY]{2})/g){
push @duplets, $1;
}
my $sequence2a = substr ($sequence1a,1,);
while ($sequence2a =~ /([ACDEFGHIKLMNPQRSTVWY]{2})/g){
push @duplets, $1;
}
#Creates hash that maps duplets to their frequency
my %duplet_counter =();
for (@duplets) {
$duplet_counter{$_}++;
}
my @printarray2 =();
while (my ($key, $value) = each %duplet_counter) {
my $output = "$key ===> $value";
push @printarray2, $output;
}
my @sorted2 =();
my @sorted2 = sort {$a cmp $b} @printarray2; #sorts duplets alphabetically
#Creates ordered hash that maps duplet numbers to frequency
my @AA_duplet_ordered =();
for (@duplets) {
push @AA_duplet_ordered, $AA_duplet_numbering{$_};
}
#Creates ordered hash that maps duplet numbers to frequency
print "\n","AA_duplet_numb => frequency:","\n";
my %duplet_counterb =();
for (@AA_duplet_ordered) {
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$duplet_counterb{$_}++;
}
my @printarray2f =();
#Orders hash keys into new array
my @duplet_counterb_temp =();
my @duplet_counterb_temp = sort {$a <=> $b} (keys %duplet_counterb);
for (@duplet_counterb_temp) {
my $key = $_+(400*$x);
my $value = $duplet_counterb{$_};
my $valuef = $value / ($seq_length1a -1);
my $output = "$key ===> $valuef";
push @printarray2f, $output;
print OUTFILE "$key:$valuef ";
}
$x=$x+1;
}
print OUTFILE "\n";
}
close (OUTFILE);
Multiple Sequence Alignment Shannon Entropy Calculator
#This script streams in one input file:
#1) FASTA-formatted multiple sequence alignment
#And generates one file:
#1) CSV formatted-file containing MSA positions and corresponding entropy values
#!/usr/bin/perl
use strict;
use warnings;
#Spreadsheet header
open OUTFILE, (">entropy.csv");
print OUTFILE "Position",",","Entropy","\n";
#Read in MSA (fasta) and amass into single string
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my $z;
while ($_ = <>) {
if ($_ =~ />/) {
chomp $_;
$_=$_."&";
}
chomp $_;
$z.=$_;
}
$z =~s/\s//g;
my $z2=$z;
#Logarithm subroutine
sub log_base {
my ($base, $value) = @_;
return log($value)/log($base);
}
#Find sequence length
my $alength = ’’;
if ($z2 =~ />.*?\&([ACDEFGHIKLMNPQRSTVWYX-]+)/) {
my $atemp = $1;
$alength = length ($atemp);
}
#Find number of sequences
my $k=0;
while ($z2 =~ />/g) {
$k=$k+1;
}
my $seqnumber = $k;
#Calculate Shannon Entropy for each position in alignment
my $i=0;
for ($i=0; $i<$alength; $i++){
print "ARRAY POSITION NUMBER: ",$i+1;
print OUTFILE $i+1,",";
my @singlets;
while ($z =~ />.*?\&([ACDEFGHIKLMNPQRSTVWYX-]+)/g){
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my $letters = substr ($1,$i,1);
push @singlets, $letters;
}
print join ’ ’, @singlets;
#Create a counter for this position
my %singlet_counter;
for (@singlets) {
$singlet_counter{$_}++;
}
my @printarray;
my @printarray2;
#Only consider columns where seqs with gap < 1/4th of the total seq number
#Otherwise entropy set to default arbitrarily high value (5)
my $seqnumberb = $seqnumber/4;
my $entropy = 5;
if ($singlet_counter{’-’} < $seqnumberb){
$entropy = 0;
#Counts instances of each aa for given column, converts to probabilities
#Calculates Shannon entropy with probabilities
while (my ($key, $value) = each %singlet_counter) {
my $prob = $value/$seqnumber;
my $templog = log_base(2,$prob);
$templog = (-1)*$prob*$templog;
$entropy = $entropy+$templog;
my $output2 = "$key ===> $value";
push @printarray1, $output2;
my $output = "$key ===> $templog";
push @printarray2, $output;
}
}
#Print frequencies, probabilities, and entropy to screen
print "AA => frequency:","\n";
print join "\n", @printarray1;
print "\n";
print "AA => probability:","\n";
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print join "\n", @printarray2;
print "\n";
print "ENTROPY: ", $entropy,"\n";
#Print entropy to CSV file
print OUTFILE2 $entropy,"\n";
}
close (OUTFILE);
BLAST parser
#This script streams in one input file:
#1) Blast result output file (txt) generated with netblast-2.2.18
#And generates one output file:
#1) CSV formatted-file containing information about top Blast hats
#!/usr/bin/perl
use strict;
use warnings;
#Reads in Blast output file and stores in single string
my $a;
while ($_ = <>) {
chomp $_;
$a.=$_;
}
#Creates csv file, fills out first row with desired parameter list
open(OUTFILE, ">BLAST.csv");
print OUTFILE "query id,query length...","\n";
#Regular expression extract query and hit information
while ($a =~ /Query=\s([^\s]*?)\s.*?\(([0-9]+)\sletters\)(.*?)Lambda/g){
my $queryid = $1; # query id
my $querylength = $2; #query length
my $region = $3; #region
print OUTFILE $queryid,",",$querylength,"\n";
while ($region =~ /\>(ref.*?)\s(.*?)\[(.*?)\].*?Length\s=\s([0-9]+).*?
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Expect\s=\s(.*?)\s+Identities\s=\s(.*?),/g){
my $hitid = $1; #hit id
my $hitannotation = $2; #hit annotation
my $hitspecies = $3; #hit species
my $hitlength = $4; #hit length
my $hiteval = $5; #hit E-value
my $hitidentity = $6; #hit identity
$hitannotation =~s/\s{2,}/\s/g;
$hitannotation =~s/,/\s/g;
$hitspecies =~s/\s{2,}/\s/g;
print OUTFILE " ",","," ",",";
#Choose and print parameters of interest to file
print OUTFILE $hitid,...,"\n";
}
}
close OUTFILE;
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